{"results":[{"start_date":"2011-01-01","end_date":"2011-03-31","filing_date":"2011-05-03","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2011","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001206774-11-001105","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001206774-11-001105/files/regn-20110331.xml","financials":{"balance_sheet":{"equity":{"value":518091000.0,"unit":"USD","label":"Equity","order":1400},"other_noncurrent_assets":{"value":391369000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_liabilities":{"value":443950000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":556202000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_assets":{"value":748792000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":325501000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":357423000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_liabilities":{"value":112252000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities_and_equity":{"value":1074293000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"assets":{"value":1074293000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_parent":{"value":518091000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-43447000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":-43447000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"income_loss_from_continuing_operations_before_tax":{"value":-43663000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"costs_and_expenses":{"value":153185000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_income_loss":{"value":-40981000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_attributable_to_parent":{"value":-43447000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_expenses":{"value":152803000.0,"unit":"USD","label":"Operating Expenses","order":1000},"cost_of_revenue_goods":{"value":382000,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_tax_expense_benefit":{"value":-216000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_before_equity_method_investments":{"value":-43663000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"selling_general_and_administrative_expenses":{"value":23411000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"nonoperating_income_loss":{"value":-2682000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_loss_from_continuing_operations_after_tax":{"value":-43447000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"cost_of_revenue":{"value":382000,"unit":"USD","label":"Cost Of Revenue","order":300},"research_and_development":{"value":129392000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_available_to_common_stockholders_basic":{"value":-43447000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"revenues":{"value":112204000.0,"unit":"USD","label":"Revenues","order":100},"interest_expense_operating":{"value":3719000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss":{"value":-43447000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"gross_profit":{"value":111822000.0,"unit":"USD","label":"Gross Profit","order":800},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200}},"cash_flow_statement":{"net_cash_flow":{"value":22804000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":20347000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":20347000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":22804000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":-10580000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":13037000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":-10580000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":13037000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800}}}},{"start_date":"2011-04-01","end_date":"2011-06-30","filing_date":"2011-07-28","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2011","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001206774-11-001639","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001206774-11-001639/files/regn-20110630.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":-34050000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":10051000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":118936000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":142935000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":142935000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":10051000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":-34050000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":118936000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"balance_sheet":{"liabilities":{"value":568830000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_liabilities":{"value":109839000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"wages":{"value":26029000.0,"unit":"USD","label":"Wages","order":730},"other_noncurrent_assets":{"value":271708000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":633591000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":413273000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":478034000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":432962000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"fixed_assets":{"value":361883000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities_and_equity":{"value":1046864000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"assets":{"value":1046864000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_parent":{"value":478034000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_liabilities":{"value":135868000.0,"unit":"USD","label":"Current Liabilities","order":700}},"comprehensive_income":{"comprehensive_income_loss":{"value":-62505000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":-61234000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"interest_expense_operating":{"value":4047000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_before_tax":{"value":-63368000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"revenues":{"value":107810000.0,"unit":"USD","label":"Revenues","order":100},"costs_and_expenses":{"value":168129000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss":{"value":-62505000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"cost_of_revenue":{"value":395000,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_income_loss":{"value":-60319000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"gross_profit":{"value":107415000.0,"unit":"USD","label":"Gross Profit","order":800},"income_tax_expense_benefit":{"value":-863000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"research_and_development":{"value":143149000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_from_continuing_operations_after_tax":{"value":-62505000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"cost_of_revenue_goods":{"value":395000,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_expenses":{"value":167734000.0,"unit":"USD","label":"Operating Expenses","order":1000},"nonoperating_income_loss":{"value":-3049000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_loss_before_equity_method_investments":{"value":-63368000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"selling_general_and_administrative_expenses":{"value":24585000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_parent":{"value":-62505000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss_available_to_common_stockholders_basic":{"value":-62505000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700}}}},{"start_date":"2011-07-01","end_date":"2011-09-30","filing_date":"2011-10-27","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2011","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001206774-11-002300","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001206774-11-002300/files/regn-20110930.xml","financials":{"balance_sheet":{"current_liabilities":{"value":133235000.0,"unit":"USD","label":"Current Liabilities","order":700},"wages":{"value":37616000.0,"unit":"USD","label":"Wages","order":730},"assets":{"value":983031000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_parent":{"value":428253000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities":{"value":554778000.0,"unit":"USD","label":"Liabilities","order":600},"other_noncurrent_assets":{"value":279246000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_liabilities":{"value":95619000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities_and_equity":{"value":983031000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":421543000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity":{"value":428253000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"fixed_assets":{"value":363913000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_assets":{"value":643159000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":339872000.0,"unit":"USD","label":"Current Assets","order":200}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":-279000,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-903000,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":-47917000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-903000,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":-47917000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":-279000,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":-46735000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":-46735000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"income_statement":{"income_tax_expense_benefit":{"value":562000,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_before_equity_method_investments":{"value":-61803000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"interest_expense_operating":{"value":4061000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"revenues":{"value":102833000.0,"unit":"USD","label":"Revenues","order":100},"gross_profit":{"value":102383000.0,"unit":"USD","label":"Gross Profit","order":800},"costs_and_expenses":{"value":161290000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_parent":{"value":-62365000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"operating_expenses":{"value":160840000.0,"unit":"USD","label":"Operating Expenses","order":1000},"selling_general_and_administrative_expenses":{"value":32916000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"cost_of_revenue_goods":{"value":450000,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_income_loss":{"value":-58457000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_available_to_common_stockholders_basic":{"value":-62365000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":127924000.0,"unit":"USD","label":"Research and Development","order":1030},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss":{"value":-62365000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"cost_of_revenue":{"value":450000,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_from_continuing_operations_after_tax":{"value":-62365000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"nonoperating_income_loss":{"value":-3346000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_before_tax":{"value":-61803000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":-63192000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":-62365000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2011-01-01","end_date":"2011-12-31","filing_date":"2012-02-21","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2011","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001206774-12-000709","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001206774-12-000709/files/regn-20111231.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":-141682000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":384249000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":371038000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":-141682000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":384249000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":128471000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":128471000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":371038000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"income_statement":{"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"nonoperating_income_loss":{"value":-17733000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"cost_of_revenue_goods":{"value":4216000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_from_continuing_operations_after_tax":{"value":-221760000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_loss_before_equity_method_investments":{"value":-222892000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"research_and_development":{"value":529506000.0,"unit":"USD","label":"Research and Development","order":1030},"income_loss_from_continuing_operations_before_tax":{"value":-222892000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"costs_and_expenses":{"value":650983000.0,"unit":"USD","label":"Costs And Expenses","order":600},"selling_general_and_administrative_expenses":{"value":117261000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"revenues":{"value":445824000.0,"unit":"USD","label":"Revenues","order":100},"benefits_costs_expenses":{"value":668716000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_expense_operating":{"value":21282000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_available_to_common_stockholders_basic":{"value":-221760000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"cost_of_revenue":{"value":4216000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_parent":{"value":-221760000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss":{"value":-221760000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"operating_expenses":{"value":646767000.0,"unit":"USD","label":"Operating Expenses","order":1000},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"gross_profit":{"value":441608000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_income_loss":{"value":-205159000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit":{"value":-1132000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}},"balance_sheet":{"liabilities":{"value":837851000.0,"unit":"USD","label":"Liabilities","order":600},"equity":{"value":485732000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":652875000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":367955000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_assets":{"value":670708000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":1323583000.0,"unit":"USD","label":"Assets","order":100},"other_current_liabilities":{"value":105436000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"wages":{"value":42835000.0,"unit":"USD","label":"Wages","order":730},"current_liabilities":{"value":148271000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":689580000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities_and_equity":{"value":1323583000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_noncurrent_assets":{"value":302753000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_parent":{"value":485732000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600}},"comprehensive_income":{"comprehensive_income_loss":{"value":-221760000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":-221760000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2012-01-01","end_date":"2012-03-31","filing_date":"2012-04-26","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2012","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001206774-12-001689","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001206774-12-001689/files/regn-20120331.xml","financials":{"balance_sheet":{"wages":{"value":34336000.0,"unit":"USD","label":"Wages","order":730},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_liabilities":{"value":685749000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_liabilities":{"value":160386000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_assets":{"value":690715000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_assets":{"value":653244000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":1350159000.0,"unit":"USD","label":"Assets","order":100},"other_noncurrent_assets":{"value":283285000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"fixed_assets":{"value":369959000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_assets":{"value":696915000.0,"unit":"USD","label":"Current Assets","order":200},"inventory":{"value":6200000.0,"unit":"USD","label":"Inventory","order":230},"other_current_liabilities":{"value":126050000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities":{"value":846135000.0,"unit":"USD","label":"Liabilities","order":600},"equity":{"value":504024000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_parent":{"value":504024000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities_and_equity":{"value":1350159000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":12176000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":11651000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"income_statement":{"income_loss_from_continuing_operations_before_tax":{"value":11651000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"cost_of_revenue":{"value":12298000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_average_shares":{"value":107734000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_average_shares":{"value":93446000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"operating_income_loss":{"value":22201000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"gross_profit":{"value":219491000.0,"unit":"USD","label":"Gross Profit","order":800},"interest_expense_operating":{"value":11160000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"costs_and_expenses":{"value":209588000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_parent":{"value":11651000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_earnings_per_share":{"value":0.11,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_tax_expense_benefit":{"value":0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_earnings_per_share":{"value":0.12,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"nonoperating_income_loss":{"value":-10550000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"selling_general_and_administrative_expenses":{"value":58428000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss":{"value":11651000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"revenues":{"value":231789000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_available_to_common_stockholders_basic":{"value":11651000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_before_equity_method_investments":{"value":11651000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_expenses":{"value":197290000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_after_tax":{"value":11651000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"cost_of_revenue_goods":{"value":12298000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"research_and_development":{"value":138862000.0,"unit":"USD","label":"Research and Development","order":1030}},"cash_flow_statement":{"net_cash_flow":{"value":-89025000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":-17750000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":-89025000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":15766000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":15766000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":-87041000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":-87041000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":-17750000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800}}}},{"start_date":"2012-04-01","end_date":"2012-06-30","filing_date":"2012-07-25","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2012","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001206774-12-003062","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001206774-12-003062/files/regn-20120630.xml","financials":{"income_statement":{"costs_and_expenses":{"value":216921000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_loss_before_equity_method_investments":{"value":76743000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"diluted_earnings_per_share":{"value":0.7,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"nonoperating_income_loss":{"value":-10735000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"diluted_average_shares":{"value":110167000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_continuing_operations_after_tax":{"value":76743000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"cost_of_revenue":{"value":21843000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_income_loss":{"value":87478000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_attributable_to_parent":{"value":76743000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"selling_general_and_administrative_expenses":{"value":47705000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_expenses":{"value":195078000.0,"unit":"USD","label":"Operating Expenses","order":1000},"gross_profit":{"value":282556000.0,"unit":"USD","label":"Gross Profit","order":800},"revenues":{"value":304399000.0,"unit":"USD","label":"Revenues","order":100},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_tax_expense_benefit":{"value":0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"interest_expense_operating":{"value":11236000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_before_tax":{"value":76743000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"basic_earnings_per_share":{"value":0.81,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"basic_average_shares":{"value":94589000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"research_and_development":{"value":147373000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss":{"value":76743000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"cost_of_revenue_goods":{"value":21843000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_available_to_common_stockholders_basic":{"value":76743000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300}},"balance_sheet":{"equity":{"value":594657000.0,"unit":"USD","label":"Equity","order":1400},"other_current_assets":{"value":758693000.0,"unit":"USD","label":"Other Current Assets","order":250},"inventory":{"value":10500000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":594657000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"wages":{"value":35458000.0,"unit":"USD","label":"Wages","order":730},"current_assets":{"value":769193000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_liabilities":{"value":147762000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"assets":{"value":1457500000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":372278000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_assets":{"value":688307000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_noncurrent_assets":{"value":316029000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":862843000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":1457500000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_liabilities":{"value":183220000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":679623000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-5077000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":-222642000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":-222642000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":-78377000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-5077000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-139188000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":-78377000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-139188000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":75709000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":76743000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2012-07-01","end_date":"2012-09-30","filing_date":"2012-10-24","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2012","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-12-000004","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-12-000004/files/regn-20120930.xml","financials":{"balance_sheet":{"equity":{"value":806024000.0,"unit":"USD","label":"Equity","order":1400},"fixed_assets":{"value":372917000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities":{"value":854591000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":1660615000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_noncurrent_assets":{"value":339095000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":948603000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_assets":{"value":919033000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_assets":{"value":712012000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"wages":{"value":46620000.0,"unit":"USD","label":"Wages","order":730},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_liabilities":{"value":131948000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":806024000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":1660615000.0,"unit":"USD","label":"Assets","order":100},"inventory":{"value":29570000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":676023000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_liabilities":{"value":178568000.0,"unit":"USD","label":"Current Liabilities","order":700}},"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":-2382000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities_continuing":{"value":-1809000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":-52945000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":-52945000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":-48754000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":-2382000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":-1809000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-48754000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":191468000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":191935000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"gross_profit":{"value":407542000.0,"unit":"USD","label":"Gross Profit","order":800},"income_loss_from_continuing_operations_before_tax":{"value":191468000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_average_shares":{"value":95012000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"cost_of_revenue_goods":{"value":20145000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"nonoperating_income_loss":{"value":-10896000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"revenues":{"value":427687000.0,"unit":"USD","label":"Revenues","order":100},"operating_expenses":{"value":205178000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_before_equity_method_investments":{"value":191468000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss":{"value":191468000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"research_and_development":{"value":158295000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_available_to_common_stockholders_basic":{"value":191468000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_continuing_operations_after_tax":{"value":191468000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"cost_of_revenue":{"value":20145000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_income_loss":{"value":202364000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"diluted_earnings_per_share":{"value":1.72,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_earnings_per_share":{"value":2.02,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"diluted_average_shares":{"value":115830000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"costs_and_expenses":{"value":225323000.0,"unit":"USD","label":"Costs And Expenses","order":600},"interest_expense_operating":{"value":11413000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"selling_general_and_administrative_expenses":{"value":46883000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_parent":{"value":191468000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900}}}},{"start_date":"2012-01-01","end_date":"2012-12-31","filing_date":"2013-02-15","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2012","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-13-000004","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-13-000004/files/regn-20121231.xml","financials":{"balance_sheet":{"other_current_liabilities":{"value":143563000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity":{"value":1245385000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_parent":{"value":1245385000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities":{"value":835105000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":28638000.0,"unit":"USD","label":"Inventory","order":230},"assets":{"value":2080490000.0,"unit":"USD","label":"Assets","order":100},"current_assets":{"value":1206012000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities_and_equity":{"value":2080490000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_liabilities":{"value":163550000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":671555000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_assets":{"value":1177374000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"fixed_assets":{"value":379940000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_assets":{"value":874478000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_noncurrent_assets":{"value":494538000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"wages":{"value":19987000.0,"unit":"USD","label":"Wages","order":730}},"income_statement":{"income_loss_from_continuing_operations_after_tax":{"value":750269000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_earnings_per_share":{"value":7.92,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"cost_of_revenue_goods":{"value":84455000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"benefits_costs_expenses":{"value":964056000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss":{"value":750269000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"selling_general_and_administrative_expenses":{"value":210755000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_expenses":{"value":836309000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_earnings_per_share":{"value":6.75,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"gross_profit":{"value":1294022000.0,"unit":"USD","label":"Gross Profit","order":800},"income_loss_before_equity_method_investments":{"value":414421000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"cost_of_revenue":{"value":84455000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"diluted_average_shares":{"value":115382000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"operating_income_loss":{"value":457713000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"research_and_development":{"value":625554000.0,"unit":"USD","label":"Research and Development","order":1030},"income_tax_expense_benefit":{"value":-335848000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"interest_expense_operating":{"value":45304000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_tax_expense_benefit_current":{"value":4308000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"basic_average_shares":{"value":94685000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_parent":{"value":750269000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss_available_to_common_stockholders_basic":{"value":750269000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_from_continuing_operations_before_tax":{"value":414421000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"revenues":{"value":1378477000.0,"unit":"USD","label":"Revenues","order":100},"costs_and_expenses":{"value":920764000.0,"unit":"USD","label":"Costs And Expenses","order":600},"nonoperating_income_loss":{"value":-43292000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":750965000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":750965000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":750965000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":-81073000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":-253334000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-81073000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-97646000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":-74615000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":-253334000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":-97646000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":-74615000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}}}},{"start_date":"2013-01-01","end_date":"2013-03-31","filing_date":"2013-05-03","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2013","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-13-000008","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-13-000008/files/regn-20130331.xml","financials":{"cash_flow_statement":{"net_cash_flow":{"value":-49914000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":11523000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-147685000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-147685000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":86248000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":86248000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":11523000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":-49914000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"balance_sheet":{"current_assets":{"value":1307122000.0,"unit":"USD","label":"Current Assets","order":200},"current_liabilities":{"value":197244000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_parent":{"value":1406348000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities":{"value":869650000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":2275998000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"assets":{"value":2275998000.0,"unit":"USD","label":"Assets","order":100},"other_noncurrent_assets":{"value":576498000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"inventory":{"value":43977000.0,"unit":"USD","label":"Inventory","order":230},"wages":{"value":32385000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_liabilities":{"value":672406000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_assets":{"value":1263145000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity":{"value":1406348000.0,"unit":"USD","label":"Equity","order":1400},"other_current_liabilities":{"value":164859000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":968876000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"fixed_assets":{"value":392378000.0,"unit":"USD","label":"Fixed Assets","order":320}},"income_statement":{"net_income_loss_attributable_to_parent":{"value":98874000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"cost_of_revenue":{"value":29055000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_before_equity_method_investments":{"value":141831000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"diluted_earnings_per_share":{"value":0.9,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_available_to_common_stockholders_basic":{"value":98874000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_tax_expense_benefit":{"value":42957000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_income_loss":{"value":153050000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"revenues":{"value":439664000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_after_tax":{"value":98874000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"selling_general_and_administrative_expenses":{"value":77260000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"diluted_average_shares":{"value":109369000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":98874000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":286614000.0,"unit":"USD","label":"Costs And Expenses","order":600},"basic_earnings_per_share":{"value":1.02,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"basic_average_shares":{"value":96878000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_before_tax":{"value":141831000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"interest_expense_operating":{"value":11675000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"gross_profit":{"value":410609000.0,"unit":"USD","label":"Gross Profit","order":800},"nonoperating_income_loss":{"value":-11219000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"cost_of_revenue_goods":{"value":29055000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_expenses":{"value":257559000.0,"unit":"USD","label":"Operating Expenses","order":1000},"research_and_development":{"value":180299000.0,"unit":"USD","label":"Research and Development","order":1030},"other_operating_expenses":{"value":1034000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":98396000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":98874000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}}}},{"start_date":"2013-04-01","end_date":"2013-06-30","filing_date":"2013-08-06","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2013","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-13-000022","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-13-000022/files/regn-20130630.xml","financials":{"balance_sheet":{"current_liabilities":{"value":203802000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":681120000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"wages":{"value":39760000.0,"unit":"USD","label":"Wages","order":730},"inventory":{"value":57159000.0,"unit":"USD","label":"Inventory","order":230},"fixed_assets":{"value":419651000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_noncurrent_assets":{"value":397246000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":816897000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity":{"value":1493337000.0,"unit":"USD","label":"Equity","order":1400},"other_current_liabilities":{"value":164042000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":1493337000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities_and_equity":{"value":2378259000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":1504203000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":1561362000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities":{"value":884922000.0,"unit":"USD","label":"Liabilities","order":600},"assets":{"value":2378259000.0,"unit":"USD","label":"Assets","order":100}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":116630000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":201313000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":128164000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":201313000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":-43481000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":-43481000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":128164000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":116630000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"income_statement":{"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"interest_expense_operating":{"value":11365000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_after_tax":{"value":87376000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_expenses":{"value":272256000.0,"unit":"USD","label":"Operating Expenses","order":1000},"gross_profit":{"value":430359000.0,"unit":"USD","label":"Gross Profit","order":800},"basic_average_shares":{"value":97700000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"cost_of_revenue_goods":{"value":27283000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"cost_of_revenue":{"value":27283000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_earnings_per_share":{"value":0.79,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_earnings_per_share":{"value":0.89,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_parent":{"value":87376000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss_available_to_common_stockholders_basic":{"value":87376000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"other_operating_expenses":{"value":12330000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"research_and_development":{"value":187463000.0,"unit":"USD","label":"Research and Development","order":1030},"selling_general_and_administrative_expenses":{"value":72463000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_before_equity_method_investments":{"value":147692000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_income_loss":{"value":158103000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"revenues":{"value":457642000.0,"unit":"USD","label":"Revenues","order":100},"nonoperating_income_loss":{"value":-10411000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"diluted_average_shares":{"value":111060000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit":{"value":60316000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"costs_and_expenses":{"value":299539000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss":{"value":87376000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_from_continuing_operations_before_tax":{"value":147692000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":85591000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":87376000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2013-07-01","end_date":"2013-09-30","filing_date":"2013-11-05","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2013","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-13-000030","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-13-000030/files/regn-20130930.xml","financials":{"income_statement":{"income_loss_from_continuing_operations_after_tax":{"value":141306000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"costs_and_expenses":{"value":360225000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_expenses":{"value":331972000.0,"unit":"USD","label":"Operating Expenses","order":1000},"revenues":{"value":597027000.0,"unit":"USD","label":"Revenues","order":100},"research_and_development":{"value":224045000.0,"unit":"USD","label":"Research and Development","order":1030},"income_loss_before_equity_method_investments":{"value":225684000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_before_tax":{"value":225684000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"cost_of_revenue_goods":{"value":28253000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_attributable_to_parent":{"value":141306000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"interest_expense_operating":{"value":11736000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"nonoperating_income_loss":{"value":-11118000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"diluted_average_shares":{"value":116713000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"gross_profit":{"value":568774000.0,"unit":"USD","label":"Gross Profit","order":800},"basic_average_shares":{"value":98226000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"selling_general_and_administrative_expenses":{"value":97607000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss":{"value":141306000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"other_operating_expenses":{"value":10320000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"basic_earnings_per_share":{"value":1.44,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_tax_expense_benefit":{"value":-20383000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_earnings_per_share":{"value":1.25,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"operating_income_loss":{"value":236802000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"cost_of_revenue":{"value":28253000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_available_to_common_stockholders_basic":{"value":141306000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":141884000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":141306000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":92455000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-214452000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":-118464000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":92455000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":-118464000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":3533000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":3533000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-214452000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"balance_sheet":{"assets":{"value":2640415000.0,"unit":"USD","label":"Assets","order":100},"equity":{"value":1690171000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":1006255000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"wages":{"value":68928000.0,"unit":"USD","label":"Wages","order":730},"other_current_liabilities":{"value":199799000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":1690171000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"inventory":{"value":63292000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_noncurrent_assets":{"value":552364000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":950244000.0,"unit":"USD","label":"Liabilities","order":600},"fixed_assets":{"value":453891000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_liabilities":{"value":268727000.0,"unit":"USD","label":"Current Liabilities","order":700},"current_assets":{"value":1634160000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_liabilities":{"value":681517000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities_and_equity":{"value":2640415000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":1570868000.0,"unit":"USD","label":"Other Current Assets","order":250}}}},{"start_date":"2013-01-01","end_date":"2013-12-31","filing_date":"2014-02-13","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2013","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-14-000008","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-14-000008/files/regn-20131231.xml","financials":{"comprehensive_income":{"comprehensive_income_loss":{"value":424340000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":424340000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":424340000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"other_operating_expenses":{"value":37307000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_tax_expense_benefit_deferred":{"value":63601000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"net_income_loss_attributable_to_parent":{"value":424362000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"cost_of_revenue":{"value":118048000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"cost_of_revenue_goods":{"value":118048000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_from_continuing_operations_after_tax":{"value":424362000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"benefits_costs_expenses":{"value":1391385000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_before_tax":{"value":713360000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"nonoperating_income_loss":{"value":-46668000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_tax_expense_benefit_current":{"value":225397000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"diluted_earnings_per_share":{"value":3.81,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"costs_and_expenses":{"value":1344717000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_expenses":{"value":1226669000.0,"unit":"USD","label":"Operating Expenses","order":1000},"basic_average_shares":{"value":97917000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_before_equity_method_investments":{"value":713360000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"selling_general_and_administrative_expenses":{"value":329415000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":1986697000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_tax_expense_benefit":{"value":288998000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"research_and_development":{"value":859947000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_income_loss":{"value":760028000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"diluted_average_shares":{"value":111290000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"interest_expense_operating":{"value":46437000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_available_to_common_stockholders_basic":{"value":424362000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"revenues":{"value":2104745000.0,"unit":"USD","label":"Revenues","order":100},"basic_earnings_per_share":{"value":4.33,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss":{"value":424362000.0,"unit":"USD","label":"Net Income/Loss","order":3200}},"cash_flow_statement":{"net_cash_flow_continuing":{"value":305332000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":583648000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":583648000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-355455000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-355455000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":77139000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":305332000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":77139000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"balance_sheet":{"fixed_assets":{"value":526983000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity":{"value":1952076000.0,"unit":"USD","label":"Equity","order":1400},"current_assets":{"value":1796934000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_parent":{"value":1952076000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_liabilities":{"value":298835000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":2951013000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_assets":{"value":1154079000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"noncurrent_liabilities":{"value":700102000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"inventory":{"value":70354000.0,"unit":"USD","label":"Inventory","order":230},"wages":{"value":69429000.0,"unit":"USD","label":"Wages","order":730},"liabilities":{"value":998937000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":2951013000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_noncurrent_assets":{"value":627096000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_liabilities":{"value":229406000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"other_current_assets":{"value":1726580000.0,"unit":"USD","label":"Other Current Assets","order":250}}}},{"start_date":"2014-01-01","end_date":"2014-03-31","filing_date":"2014-05-08","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2014","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-14-000022","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-14-000022/files/regn-20140331.xml","financials":{"balance_sheet":{"inventory":{"value":86545000.0,"unit":"USD","label":"Inventory","order":230},"current_liabilities":{"value":305068000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":1049148000.0,"unit":"USD","label":"Liabilities","order":600},"fixed_assets":{"value":600864000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_liabilities":{"value":263314000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":1871049000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":2211248000.0,"unit":"USD","label":"Equity","order":1400},"assets":{"value":3260396000.0,"unit":"USD","label":"Assets","order":100},"wages":{"value":41754000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_assets":{"value":1389347000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_parent":{"value":2211248000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_noncurrent_assets":{"value":788483000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_liabilities":{"value":744080000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities_and_equity":{"value":3260396000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":1784504000.0,"unit":"USD","label":"Other Current Assets","order":250}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-236231000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-236231000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":108954000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":53527000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":-73750000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":53527000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":108954000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":-73750000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":65443000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":68096000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"cost_of_revenue":{"value":27473000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"other_operating_expenses":{"value":16099000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"revenues":{"value":625740000.0,"unit":"USD","label":"Revenues","order":100},"selling_general_and_administrative_expenses":{"value":108850000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss":{"value":65443000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"diluted_average_shares":{"value":112151000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"interest_expense_operating":{"value":11613000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_before_equity_method_investments":{"value":175263000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"research_and_development":{"value":287379000.0,"unit":"USD","label":"Research and Development","order":1030},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_parent":{"value":65443000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":65443000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_average_shares":{"value":98709000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"operating_expenses":{"value":412328000.0,"unit":"USD","label":"Operating Expenses","order":1000},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_tax_expense_benefit":{"value":109820000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_earnings_per_share":{"value":0.66,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_available_to_common_stockholders_basic":{"value":65443000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"nonoperating_income_loss":{"value":-10676000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"costs_and_expenses":{"value":439801000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit_deferred":{"value":-8522000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"cost_of_revenue_goods":{"value":27473000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"diluted_earnings_per_share":{"value":0.58,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_loss_from_continuing_operations_before_tax":{"value":175263000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"gross_profit":{"value":598267000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_income_loss":{"value":185939000.0,"unit":"USD","label":"Operating Income/Loss","order":1100}}}},{"start_date":"2014-04-01","end_date":"2014-06-30","filing_date":"2014-08-05","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2014","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-14-000035","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-14-000035/files/regn-20140630.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":95533000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":92735000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"cash_flow_statement":{"net_cash_flow":{"value":138277000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-118123000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":327790000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-71390000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":-71390000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":138277000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":-118123000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":327790000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"income_statement":{"nonoperating_income_loss":{"value":-19287000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"operating_expenses":{"value":413349000.0,"unit":"USD","label":"Operating Expenses","order":1000},"operating_income_loss":{"value":222406000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_before_equity_method_investments":{"value":203119000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"basic_average_shares":{"value":100391000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_tax_expense_benefit":{"value":110384000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"costs_and_expenses":{"value":443294000.0,"unit":"USD","label":"Costs And Expenses","order":600},"other_operating_expenses":{"value":16434000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"gross_profit":{"value":635755000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_attributable_to_parent":{"value":92735000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"interest_expense_operating":{"value":10177000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"basic_earnings_per_share":{"value":0.92,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"revenues":{"value":665700000.0,"unit":"USD","label":"Revenues","order":100},"selling_general_and_administrative_expenses":{"value":102414000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"cost_of_revenue":{"value":29945000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_available_to_common_stockholders_basic":{"value":92735000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_tax_expense_benefit_deferred":{"value":-24021000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_from_continuing_operations_after_tax":{"value":92735000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"cost_of_revenue_goods":{"value":29945000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":294501000.0,"unit":"USD","label":"Research and Development","order":1030},"diluted_earnings_per_share":{"value":0.82,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_loss_from_continuing_operations_before_tax":{"value":203119000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"diluted_average_shares":{"value":113032000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":92735000.0,"unit":"USD","label":"Net Income/Loss","order":3200}},"balance_sheet":{"noncurrent_liabilities":{"value":735658000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_assets":{"value":1808798000.0,"unit":"USD","label":"Other Current Assets","order":250},"wages":{"value":51786000.0,"unit":"USD","label":"Wages","order":730},"equity":{"value":2368842000.0,"unit":"USD","label":"Equity","order":1400},"fixed_assets":{"value":707321000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_assets":{"value":1918695000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_liabilities":{"value":299792000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"other_noncurrent_assets":{"value":830062000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":1537383000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":109897000.0,"unit":"USD","label":"Inventory","order":230},"liabilities_and_equity":{"value":3456078000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"liabilities":{"value":1087236000.0,"unit":"USD","label":"Liabilities","order":600},"current_liabilities":{"value":351578000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":3456078000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_parent":{"value":2368842000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600}}}},{"start_date":"2014-07-01","end_date":"2014-09-30","filing_date":"2014-11-04","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2014","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-14-000046","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-14-000046/files/regn-20140930.xml","financials":{"balance_sheet":{"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":1187631000.0,"unit":"USD","label":"Liabilities","order":600},"wages":{"value":75159000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_liabilities":{"value":777431000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_assets":{"value":2200512000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_liabilities":{"value":335041000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"fixed_assets":{"value":818967000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_liabilities":{"value":410200000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_assets":{"value":2080195000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":719940000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_parent":{"value":2551788000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":2551788000.0,"unit":"USD","label":"Equity","order":1400},"liabilities_and_equity":{"value":3739419000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_assets":{"value":1538907000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":120317000.0,"unit":"USD","label":"Inventory","order":230},"assets":{"value":3739419000.0,"unit":"USD","label":"Assets","order":100}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":102352000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":79720000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"income_statement":{"income_tax_expense_benefit_deferred":{"value":-17923000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"cost_of_revenue":{"value":33655000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"selling_general_and_administrative_expenses":{"value":149748000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"cost_of_revenue_goods":{"value":33655000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_from_continuing_operations_after_tax":{"value":79720000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_loss_from_continuing_operations_before_tax":{"value":176078000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_average_shares":{"value":100796000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"research_and_development":{"value":337728000.0,"unit":"USD","label":"Research and Development","order":1030},"interest_expense_operating":{"value":9232000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"diluted_earnings_per_share":{"value":0.7,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"nonoperating_income_loss":{"value":-6641000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss":{"value":79720000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"operating_income_loss":{"value":182719000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_before_equity_method_investments":{"value":176078000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_tax_expense_benefit":{"value":96358000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_available_to_common_stockholders_basic":{"value":79720000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"basic_earnings_per_share":{"value":0.79,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"gross_profit":{"value":692133000.0,"unit":"USD","label":"Gross Profit","order":800},"diluted_average_shares":{"value":117423000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":79720000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_expenses":{"value":509414000.0,"unit":"USD","label":"Operating Expenses","order":1000},"revenues":{"value":725788000.0,"unit":"USD","label":"Revenues","order":100},"costs_and_expenses":{"value":543069000.0,"unit":"USD","label":"Costs And Expenses","order":600},"other_operating_expenses":{"value":21938000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":-123068000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":163557000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-123068000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":5930000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":46419000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":5930000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":163557000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":46419000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}}}},{"start_date":"2014-01-01","end_date":"2014-12-31","filing_date":"2015-02-12","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2014","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-15-000008","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-15-000008/files/regn-20141231.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-209269000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":113111000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":743157000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-420777000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":743157000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-420777000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":113111000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":-209269000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"income_statement":{"revenues":{"value":2819557000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_available_to_common_stockholders_basic":{"value":348074000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"gross_profit":{"value":2690527000.0,"unit":"USD","label":"Gross Profit","order":800},"benefits_costs_expenses":{"value":2043810000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"selling_general_and_administrative_expenses":{"value":504755000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"diluted_earnings_per_share":{"value":3.07,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_average_shares":{"value":100612000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"research_and_development":{"value":1271353000.0,"unit":"USD","label":"Research and Development","order":1030},"income_tax_expense_benefit_deferred":{"value":-51294000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"income_loss_from_continuing_operations_before_tax":{"value":775747000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_average_shares":{"value":113413000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":348074000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"other_operating_expenses":{"value":75988000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"basic_earnings_per_share":{"value":3.46,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"cost_of_revenue":{"value":129030000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_tax_expense_benefit_current":{"value":478967000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"interest_expense_operating":{"value":37372000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"cost_of_revenue_goods":{"value":129030000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_attributable_to_parent":{"value":348074000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_before_equity_method_investments":{"value":775747000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"costs_and_expenses":{"value":1981126000.0,"unit":"USD","label":"Costs And Expenses","order":600},"nonoperating_income_loss":{"value":-62684000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_loss_from_continuing_operations_after_tax":{"value":348074000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit":{"value":427673000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"operating_expenses":{"value":1852096000.0,"unit":"USD","label":"Operating Expenses","order":1000},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"operating_income_loss":{"value":838431000.0,"unit":"USD","label":"Operating Income/Loss","order":1100}},"balance_sheet":{"current_assets":{"value":2167461000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":974309000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_liabilities":{"value":674842000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"noncurrent_assets":{"value":1704366000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":2038600000.0,"unit":"USD","label":"Other Current Assets","order":250},"liabilities_and_equity":{"value":3871827000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_liabilities":{"value":654660000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":730057000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"assets":{"value":3871827000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":1329502000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":128861000.0,"unit":"USD","label":"Inventory","order":230},"wages":{"value":92778000.0,"unit":"USD","label":"Wages","order":730},"equity":{"value":2542325000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_parent":{"value":2542325000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_liabilities":{"value":561882000.0,"unit":"USD","label":"Other Current Liabilities","order":740}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":401513000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":401513000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":401513000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2015-01-01","end_date":"2015-03-31","filing_date":"2015-05-07","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2015","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-15-000020","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-15-000020/files/regn-20150331.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":-87502000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-129481000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":76171000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":-140812000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":-87502000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-129481000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":76171000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":-140812000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"balance_sheet":{"inventory":{"value":133863000.0,"unit":"USD","label":"Inventory","order":230},"current_liabilities":{"value":536134000.0,"unit":"USD","label":"Current Liabilities","order":700},"current_assets":{"value":2310714000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":4198573000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":1227143000.0,"unit":"USD","label":"Liabilities","order":600},"other_noncurrent_assets":{"value":777262000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_assets":{"value":2176851000.0,"unit":"USD","label":"Other Current Assets","order":250},"liabilities_and_equity":{"value":4198573000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_assets":{"value":1887859000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"wages":{"value":64112000.0,"unit":"USD","label":"Wages","order":730},"equity":{"value":2971430000.0,"unit":"USD","label":"Equity","order":1400},"other_current_liabilities":{"value":472022000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_liabilities":{"value":691009000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":2971430000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"fixed_assets":{"value":1110597000.0,"unit":"USD","label":"Fixed Assets","order":320}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":71674000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":76021000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"income_loss_from_continuing_operations_after_tax":{"value":76021000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"revenues":{"value":869612000.0,"unit":"USD","label":"Revenues","order":100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"cost_of_revenue":{"value":42570000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_average_shares":{"value":114519000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_parent":{"value":76021000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"gross_profit":{"value":827042000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_expenses":{"value":543489000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss":{"value":76021000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"research_and_development":{"value":343113000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_loss_before_equity_method_investments":{"value":276523000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"selling_general_and_administrative_expenses":{"value":158991000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"diluted_earnings_per_share":{"value":0.66,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_earnings_per_share":{"value":0.74,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"costs_and_expenses":{"value":586059000.0,"unit":"USD","label":"Costs And Expenses","order":600},"nonoperating_income_loss":{"value":-7030000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"interest_expense_operating":{"value":6169000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"other_operating_expenses":{"value":41385000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_before_tax":{"value":276523000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"cost_of_revenue_goods":{"value":42570000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_income_loss":{"value":283553000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"basic_average_shares":{"value":102227000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_available_to_common_stockholders_basic":{"value":76021000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_tax_expense_benefit":{"value":200502000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}}}},{"start_date":"2015-04-01","end_date":"2015-06-30","filing_date":"2015-08-04","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2015","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-15-000029","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-15-000029/files/regn-20150630.xml","financials":{"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":194643000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":165892000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"income_tax_expense_benefit":{"value":133353000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_earnings_per_share":{"value":1.89,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"operating_income_loss":{"value":344859000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_before_equity_method_investments":{"value":327996000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"operating_expenses":{"value":592903000.0,"unit":"USD","label":"Operating Expenses","order":1000},"nonoperating_income_loss":{"value":-16863000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"costs_and_expenses":{"value":653758000.0,"unit":"USD","label":"Costs And Expenses","order":600},"basic_average_shares":{"value":102886000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"gross_profit":{"value":937762000.0,"unit":"USD","label":"Gross Profit","order":800},"income_loss_from_continuing_operations_before_tax":{"value":327996000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"interest_expense_operating":{"value":2748000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"cost_of_revenue":{"value":60855000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_average_shares":{"value":115259000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":194643000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"revenues":{"value":998617000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss":{"value":194643000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_after_tax":{"value":194643000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"selling_general_and_administrative_expenses":{"value":174588000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_available_to_common_stockholders_basic":{"value":194643000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"other_operating_expenses":{"value":27985000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_earnings_per_share":{"value":1.69,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"cost_of_revenue_goods":{"value":60855000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"research_and_development":{"value":390330000.0,"unit":"USD","label":"Research and Development","order":1030}},"cash_flow_statement":{"net_cash_flow_continuing":{"value":-117353000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":-371649000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":-117353000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-371649000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":243606000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":10690000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":10690000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":243606000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"balance_sheet":{"equity":{"value":3338458000.0,"unit":"USD","label":"Equity","order":1400},"wages":{"value":83105000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_liabilities":{"value":586970000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_liabilities":{"value":518437000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"other_noncurrent_assets":{"value":917517000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":1188512000.0,"unit":"USD","label":"Liabilities","order":600},"current_assets":{"value":2283341000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":1326112000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_assets":{"value":2112075000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_liabilities":{"value":601542000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_parent":{"value":3338458000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":4526970000.0,"unit":"USD","label":"Assets","order":100},"liabilities_and_equity":{"value":4526970000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_assets":{"value":2243629000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":171266000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500}}}},{"start_date":"2015-07-01","end_date":"2015-09-30","filing_date":"2015-11-04","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2015","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-15-000037","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-15-000037/files/regn-20150930.xml","financials":{"income_statement":{"interest_expense_operating":{"value":1715000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"diluted_earnings_per_share":{"value":1.82,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":210398000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"operating_income_loss":{"value":392422000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"research_and_development":{"value":425924000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue":{"value":67199000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"diluted_average_shares":{"value":115944000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"costs_and_expenses":{"value":745000000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_expenses":{"value":677801000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_after_tax":{"value":210398000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_average_shares":{"value":103348000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"selling_general_and_administrative_expenses":{"value":209993000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"gross_profit":{"value":1070223000.0,"unit":"USD","label":"Gross Profit","order":800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_available_to_common_stockholders_basic":{"value":210398000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_tax_expense_benefit":{"value":182891000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"revenues":{"value":1137422000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_attributable_to_parent":{"value":210398000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"cost_of_revenue_goods":{"value":67199000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"other_operating_expenses":{"value":41884000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_before_tax":{"value":393289000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"basic_earnings_per_share":{"value":2.04,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_before_equity_method_investments":{"value":393289000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"nonoperating_income_loss":{"value":867000,"unit":"USD","label":"Nonoperating Income/Loss","order":900}},"balance_sheet":{"liabilities_and_equity":{"value":5182915000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"fixed_assets":{"value":1475123000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_assets":{"value":2507275000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"wages":{"value":120933000.0,"unit":"USD","label":"Wages","order":730},"equity_attributable_to_parent":{"value":3296867000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_noncurrent_assets":{"value":1032152000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity":{"value":3296867000.0,"unit":"USD","label":"Equity","order":1400},"current_assets":{"value":2675640000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_assets":{"value":2484972000.0,"unit":"USD","label":"Other Current Assets","order":250},"inventory":{"value":190668000.0,"unit":"USD","label":"Inventory","order":230},"current_liabilities":{"value":734990000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_liabilities":{"value":614057000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"assets":{"value":5182915000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":1151058000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":1886048000.0,"unit":"USD","label":"Liabilities","order":600}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":198966000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":210398000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-283171000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":264033000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":-345649000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-283171000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-345649000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":892853000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":892853000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":264033000.0,"unit":"USD","label":"Net Cash Flow","order":1100}}}},{"start_date":"2015-01-01","end_date":"2015-12-31","filing_date":"2016-02-11","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2015","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-16-000045","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-16-000045/files/regn-20151231.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":1330780000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-262796000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":-262796000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":1330780000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":160383000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":160383000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-907601000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-907601000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"balance_sheet":{"current_liabilities":{"value":811162000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":2694037000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":2676517000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_current_liabilities":{"value":677939000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_assets":{"value":2915095000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities":{"value":1954295000.0,"unit":"USD","label":"Liabilities","order":600},"wages":{"value":133223000.0,"unit":"USD","label":"Wages","order":730},"other_noncurrent_assets":{"value":1099917000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities_and_equity":{"value":5609132000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"fixed_assets":{"value":1594120000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity":{"value":3654837000.0,"unit":"USD","label":"Equity","order":1400},"assets":{"value":5609132000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"inventory":{"value":238578000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":3654837000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_liabilities":{"value":1143133000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":592377000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":592377000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":592377000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"costs_and_expenses":{"value":2851812000.0,"unit":"USD","label":"Costs And Expenses","order":600},"basic_earnings_per_share":{"value":6.17,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_before_equity_method_investments":{"value":1225097000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_income_loss":{"value":1251916000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"cost_of_revenue":{"value":241702000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_from_continuing_operations_before_tax":{"value":1225097000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"revenues":{"value":4103728000.0,"unit":"USD","label":"Revenues","order":100},"income_tax_expense_benefit":{"value":589041000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_earnings_per_share":{"value":5.52,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"cost_of_revenue_goods":{"value":241702000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"selling_general_and_administrative_expenses":{"value":838526000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_expenses":{"value":2610110000.0,"unit":"USD","label":"Operating Expenses","order":1000},"gross_profit":{"value":3862026000.0,"unit":"USD","label":"Gross Profit","order":800},"interest_expense_operating":{"value":14241000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_after_tax":{"value":636056000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit_deferred":{"value":-130092000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"benefits_costs_expenses":{"value":2878631000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_average_shares":{"value":103061000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"nonoperating_income_loss":{"value":-26819000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss":{"value":636056000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit_current":{"value":719133000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"net_income_loss_attributable_to_parent":{"value":636056000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"research_and_development":{"value":1620577000.0,"unit":"USD","label":"Research and Development","order":1030},"other_operating_expenses":{"value":151007000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_available_to_common_stockholders_basic":{"value":636056000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"diluted_average_shares":{"value":115230000.0,"unit":"shares","label":"Diluted Average Shares","order":4500}}}},{"start_date":"2016-01-01","end_date":"2016-03-31","filing_date":"2016-05-05","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2016","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-16-000055","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-16-000055/files/regn-20160331.xml","financials":{"income_statement":{"operating_expenses":{"value":792599000.0,"unit":"USD","label":"Operating Expenses","order":1000},"gross_profit":{"value":1121907000.0,"unit":"USD","label":"Gross Profit","order":800},"research_and_development":{"value":470112000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_available_to_common_stockholders_basic":{"value":181385000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"cost_of_revenue_goods":{"value":78942000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"selling_general_and_administrative_expenses":{"value":289677000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"basic_average_shares":{"value":104290000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"cost_of_revenue":{"value":78942000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_before_equity_method_investments":{"value":330151000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_parent":{"value":181385000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"revenues":{"value":1200849000.0,"unit":"USD","label":"Revenues","order":100},"operating_income_loss":{"value":329308000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit":{"value":164415000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_earnings_per_share":{"value":1.59,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"other_operating_expenses":{"value":32810000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_average_shares":{"value":114228000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"nonoperating_income_loss":{"value":843000,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"costs_and_expenses":{"value":871541000.0,"unit":"USD","label":"Costs And Expenses","order":600},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_after_tax":{"value":181385000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_from_continuing_operations_before_tax":{"value":330151000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"basic_earnings_per_share":{"value":1.74,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss":{"value":181385000.0,"unit":"USD","label":"Net Income/Loss","order":3200}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":-190543000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":-190543000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-43685000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":29340000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":-204888000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":29340000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-43685000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":-204888000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":181385000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":161528000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"other_noncurrent_assets":{"value":1104690000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"fixed_assets":{"value":1666391000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_parent":{"value":3765082000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"wages":{"value":92668000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_assets":{"value":2771081000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities_and_equity":{"value":5904460000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"liabilities":{"value":2139378000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":2830085000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_current_liabilities":{"value":827056000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"assets":{"value":5904460000.0,"unit":"USD","label":"Assets","order":100},"equity":{"value":3765082000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_liabilities":{"value":1219654000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_assets":{"value":3133379000.0,"unit":"USD","label":"Current Assets","order":200},"inventory":{"value":303294000.0,"unit":"USD","label":"Inventory","order":230},"current_liabilities":{"value":919724000.0,"unit":"USD","label":"Current Liabilities","order":700}}}},{"start_date":"2016-04-01","end_date":"2016-06-30","filing_date":"2016-08-04","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2016","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-16-000067","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-16-000067/files/regn-20160630.xml","financials":{"income_statement":{"other_operating_expenses":{"value":27786000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_earnings_per_share":{"value":1.69,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_loss_before_equity_method_investments":{"value":292256000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_parent":{"value":196218000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"revenues":{"value":1212629000.0,"unit":"USD","label":"Revenues","order":100},"operating_expenses":{"value":879754000.0,"unit":"USD","label":"Operating Expenses","order":1000},"basic_average_shares":{"value":104633000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"nonoperating_income_loss":{"value":628000,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"research_and_development":{"value":559930000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_income_loss":{"value":291628000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"gross_profit":{"value":1171382000.0,"unit":"USD","label":"Gross Profit","order":800},"cost_of_revenue_goods":{"value":41247000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"cost_of_revenue":{"value":41247000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_average_shares":{"value":116231000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"costs_and_expenses":{"value":921001000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss":{"value":196218000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_available_to_common_stockholders_basic":{"value":196218000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"basic_earnings_per_share":{"value":1.88,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"selling_general_and_administrative_expenses":{"value":292038000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_loss_from_continuing_operations_before_tax":{"value":292256000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_after_tax":{"value":196218000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit":{"value":96038000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":-46844000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":415148000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":415148000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":-46844000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-326010000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-326010000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":42294000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":42294000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"balance_sheet":{"assets":{"value":6204906000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":1176837000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_liabilities":{"value":951563000.0,"unit":"USD","label":"Current Liabilities","order":700},"wages":{"value":114603000.0,"unit":"USD","label":"Wages","order":730},"other_current_liabilities":{"value":836960000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":2995681000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_parent":{"value":4076506000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"fixed_assets":{"value":1772923000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities_and_equity":{"value":6204906000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":2128400000.0,"unit":"USD","label":"Liabilities","order":600},"current_assets":{"value":3209225000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":4076506000.0,"unit":"USD","label":"Equity","order":1400},"inventory":{"value":316073000.0,"unit":"USD","label":"Inventory","order":230},"other_current_assets":{"value":2893152000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":1222758000.0,"unit":"USD","label":"Other Non-current Assets","order":350}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":196218000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":197058000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2016-07-01","end_date":"2016-09-30","filing_date":"2016-11-04","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2016","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-16-000082","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-16-000082/files/regn-20160930.xml","financials":{"income_statement":{"costs_and_expenses":{"value":857320000.0,"unit":"USD","label":"Costs And Expenses","order":600},"gross_profit":{"value":1190221000.0,"unit":"USD","label":"Gross Profit","order":800},"operating_income_loss":{"value":362802000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"operating_expenses":{"value":827419000.0,"unit":"USD","label":"Operating Expenses","order":1000},"basic_average_shares":{"value":104833000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"selling_general_and_administrative_expenses":{"value":270045000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_available_to_common_stockholders_basic":{"value":264804000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":543047000.0,"unit":"USD","label":"Research and Development","order":1030},"diluted_earnings_per_share":{"value":2.27,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"diluted_average_shares":{"value":116466000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_continuing_operations_after_tax":{"value":264804000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss":{"value":264804000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit":{"value":101077000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"revenues":{"value":1220122000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_before_equity_method_investments":{"value":365881000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_parent":{"value":264804000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"cost_of_revenue_goods":{"value":29901000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"basic_earnings_per_share":{"value":2.53,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_before_tax":{"value":365881000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"cost_of_revenue":{"value":29901000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"other_operating_expenses":{"value":14327000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"nonoperating_income_loss":{"value":3079000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":256701000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":264804000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-405853000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":273851000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":651029000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":273851000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":28675000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":28675000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-405853000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":651029000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}},"balance_sheet":{"liabilities_and_equity":{"value":6828019000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_assets":{"value":3501689000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":4491247000.0,"unit":"USD","label":"Equity","order":1400},"current_liabilities":{"value":961185000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":3326330000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"wages":{"value":139722000.0,"unit":"USD","label":"Wages","order":730},"other_noncurrent_assets":{"value":1454163000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"fixed_assets":{"value":1872167000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity_attributable_to_parent":{"value":4491247000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_assets":{"value":3156069000.0,"unit":"USD","label":"Other Current Assets","order":250},"assets":{"value":6828019000.0,"unit":"USD","label":"Assets","order":100},"other_current_liabilities":{"value":821463000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_liabilities":{"value":1375587000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"inventory":{"value":345620000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":2336772000.0,"unit":"USD","label":"Liabilities","order":600}}}},{"start_date":"2016-01-01","end_date":"2016-12-31","filing_date":"2017-02-09","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2016","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-17-000008","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-17-000008/files/regn-20161231.xml","financials":{"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":874110000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":874110000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":874110000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-700391000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":1473396000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":-700391000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-1046904000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":1473396000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-1046904000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":-273899000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":-273899000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"balance_sheet":{"wages":{"value":153086000.0,"unit":"USD","label":"Wages","order":730},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_liabilities":{"value":1088409000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities_and_equity":{"value":6973466000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"liabilities":{"value":2524221000.0,"unit":"USD","label":"Liabilities","order":600},"other_noncurrent_assets":{"value":1709857000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_assets":{"value":2780832000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_liabilities":{"value":1241495000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":3793278000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":3180188000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_parent":{"value":4449245000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":6973466000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":1282726000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"fixed_assets":{"value":2083421000.0,"unit":"USD","label":"Fixed Assets","order":320},"inventory":{"value":399356000.0,"unit":"USD","label":"Inventory","order":230},"equity":{"value":4449245000.0,"unit":"USD","label":"Equity","order":1400}},"income_statement":{"other_operating_expenses":{"value":105070000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_before_equity_method_investments":{"value":1329815000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_available_to_common_stockholders_basic":{"value":895522000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_average_shares":{"value":104719000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"revenues":{"value":4860427000.0,"unit":"USD","label":"Revenues","order":100},"benefits_costs_expenses":{"value":3530612000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_tax_expense_benefit":{"value":434293000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"cost_of_revenue_goods":{"value":194624000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"gross_profit":{"value":4665803000.0,"unit":"USD","label":"Gross Profit","order":800},"diluted_average_shares":{"value":116367000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"diluted_earnings_per_share":{"value":7.7,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_tax_expense_benefit_deferred":{"value":-360078000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"cost_of_revenue":{"value":194624000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_expenses":{"value":3335062000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_before_tax":{"value":1329815000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_tax_expense_benefit_current":{"value":794371000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"nonoperating_income_loss":{"value":-926000,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"costs_and_expenses":{"value":3529686000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss":{"value":895522000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"selling_general_and_administrative_expenses":{"value":1177697000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"research_and_development":{"value":2052295000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_attributable_to_parent":{"value":895522000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":895522000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_earnings_per_share":{"value":8.55,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"operating_income_loss":{"value":1330741000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300}}}},{"start_date":"2017-01-01","end_date":"2017-03-31","filing_date":"2017-05-04","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2017","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-17-000017","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-17-000017/files/regn-20170331.xml","financials":{"balance_sheet":{"liabilities_and_equity":{"value":7817365000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_parent":{"value":4866021000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":4866021000.0,"unit":"USD","label":"Equity","order":1400},"wages":{"value":94088000.0,"unit":"USD","label":"Wages","order":730},"other_noncurrent_assets":{"value":1871073000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":4148102000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":3669263000.0,"unit":"USD","label":"Current Assets","order":200},"inventory":{"value":466576000.0,"unit":"USD","label":"Inventory","order":230},"fixed_assets":{"value":2277029000.0,"unit":"USD","label":"Fixed Assets","order":320},"assets":{"value":7817365000.0,"unit":"USD","label":"Assets","order":100},"other_current_liabilities":{"value":1214183000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_liabilities":{"value":1643073000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_assets":{"value":3202687000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_liabilities":{"value":1308271000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":2951344000.0,"unit":"USD","label":"Liabilities","order":600}},"comprehensive_income":{"comprehensive_income_loss":{"value":248931000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":255887000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"diluted_average_shares":{"value":115106000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_available_to_common_stockholders_basic":{"value":248931000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"cost_of_revenue":{"value":61253000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_before_equity_method_investments":{"value":432289000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_loss_from_continuing_operations_after_tax":{"value":248931000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"costs_and_expenses":{"value":888449000.0,"unit":"USD","label":"Costs And Expenses","order":600},"diluted_earnings_per_share":{"value":2.16,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_tax_expense_benefit":{"value":183358000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss":{"value":248931000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"basic_earnings_per_share":{"value":2.36,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_before_tax":{"value":432289000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_expenses":{"value":827196000.0,"unit":"USD","label":"Operating Expenses","order":1000},"gross_profit":{"value":1257738000.0,"unit":"USD","label":"Gross Profit","order":800},"revenues":{"value":1318991000.0,"unit":"USD","label":"Revenues","order":100},"selling_general_and_administrative_expenses":{"value":296846000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"research_and_development":{"value":507435000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_attributable_to_parent":{"value":248931000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"nonoperating_income_loss":{"value":1747000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"basic_average_shares":{"value":105572000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"other_operating_expenses":{"value":22915000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"cost_of_revenue_goods":{"value":61253000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_income_loss":{"value":430542000.0,"unit":"USD","label":"Operating Income/Loss","order":1100}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":-140143000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":355901000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":60812000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":276570000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":276570000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":355901000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-140143000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":60812000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}}}},{"start_date":"2017-04-01","end_date":"2017-06-30","filing_date":"2017-08-03","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2017","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-17-000027","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-17-000027/files/regn-20170630.xml","financials":{"balance_sheet":{"wages":{"value":146438000.0,"unit":"USD","label":"Wages","order":730},"equity_attributable_to_parent":{"value":5520738000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities_and_equity":{"value":8106373000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_noncurrent_assets":{"value":1984620000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":3860051000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_liabilities":{"value":1556618000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"inventory":{"value":554320000.0,"unit":"USD","label":"Inventory","order":230},"assets":{"value":8106373000.0,"unit":"USD","label":"Assets","order":100},"other_current_assets":{"value":3305731000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"fixed_assets":{"value":2261702000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_liabilities":{"value":882579000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity":{"value":5520738000.0,"unit":"USD","label":"Equity","order":1400},"liabilities":{"value":2585635000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_assets":{"value":4246322000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":1029017000.0,"unit":"USD","label":"Current Liabilities","order":700}},"income_statement":{"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":509975000.0,"unit":"USD","label":"Research and Development","order":1030},"costs_and_expenses":{"value":919804000.0,"unit":"USD","label":"Costs And Expenses","order":600},"cost_of_revenue":{"value":42133000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"basic_earnings_per_share":{"value":3.66,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"gross_profit":{"value":1427983000.0,"unit":"USD","label":"Gross Profit","order":800},"diluted_earnings_per_share":{"value":3.34,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"operating_income_loss":{"value":550312000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"revenues":{"value":1470116000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_after_tax":{"value":387744000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_expenses":{"value":877671000.0,"unit":"USD","label":"Operating Expenses","order":1000},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_tax_expense_benefit":{"value":138106000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"nonoperating_income_loss":{"value":-24462000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss":{"value":387744000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_before_equity_method_investments":{"value":525850000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"cost_of_revenue_goods":{"value":42133000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"selling_general_and_administrative_expenses":{"value":306908000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"basic_average_shares":{"value":106034000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_available_to_common_stockholders_basic":{"value":387744000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"diluted_average_shares":{"value":116137000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"other_operating_expenses":{"value":60788000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_attributable_to_parent":{"value":387744000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_before_tax":{"value":525850000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500}},"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":-30570000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":133519000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":-67460000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":-67460000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities":{"value":-170409000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":-30570000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":133519000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-170409000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":395976000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":387744000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}}}},{"start_date":"2017-07-01","end_date":"2017-09-30","filing_date":"2017-11-08","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2017","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-17-000034","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-17-000034/files/regn-20170930.xml","financials":{"balance_sheet":{"wages":{"value":166102000.0,"unit":"USD","label":"Wages","order":730},"current_liabilities":{"value":1138628000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":8701215000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":2274529000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities_and_equity":{"value":8701215000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_noncurrent_assets":{"value":2290944000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_liabilities":{"value":972526000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":6051593000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"inventory":{"value":641588000.0,"unit":"USD","label":"Inventory","order":230},"equity":{"value":6051593000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":4565473000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":4135742000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities":{"value":2649622000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":3494154000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_liabilities":{"value":1510994000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800}},"income_statement":{"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_average_shares":{"value":106706000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"revenues":{"value":1500673000.0,"unit":"USD","label":"Revenues","order":100},"cost_of_revenue":{"value":46388000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"income_loss_from_continuing_operations_after_tax":{"value":388317000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_attributable_to_parent":{"value":388317000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_earnings_per_share":{"value":3.32,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"gross_profit":{"value":1454285000.0,"unit":"USD","label":"Gross Profit","order":800},"nonoperating_income_loss":{"value":5679000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss":{"value":388317000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"operating_income_loss":{"value":559926000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"cost_of_revenue_goods":{"value":46388000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"operating_expenses":{"value":894359000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_average_shares":{"value":117028000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_continuing_operations_before_tax":{"value":565605000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"selling_general_and_administrative_expenses":{"value":306766000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":940747000.0,"unit":"USD","label":"Costs And Expenses","order":600},"other_operating_expenses":{"value":57844000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_available_to_common_stockholders_basic":{"value":388317000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_tax_expense_benefit":{"value":177288000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_before_equity_method_investments":{"value":565605000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"basic_earnings_per_share":{"value":3.64,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"research_and_development":{"value":529749000.0,"unit":"USD","label":"Research and Development","order":1030}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-358884000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":-8196000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":47752000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":47752000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-358884000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":414832000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":414832000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":-8196000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":409804000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":388317000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2017-01-01","end_date":"2017-12-31","filing_date":"2018-02-08","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2017","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-18-000013","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-18-000013/files/regn-20171231.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":1307112000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-24400000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":-24400000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":1307112000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":277530000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_investing_activities_continuing":{"value":-1005182000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":277530000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-1005182000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"balance_sheet":{"assets":{"value":8764286000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"wages":{"value":191825000.0,"unit":"USD","label":"Wages","order":730},"equity_attributable_to_parent":{"value":6144078000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities":{"value":2620208000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":8764286000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":1484725000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_liabilities":{"value":943658000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"other_current_assets":{"value":3608892000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":4335030000.0,"unit":"USD","label":"Current Assets","order":200},"current_liabilities":{"value":1135483000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity":{"value":6144078000.0,"unit":"USD","label":"Equity","order":1400},"fixed_assets":{"value":2358605000.0,"unit":"USD","label":"Fixed Assets","order":320},"inventory":{"value":726138000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_assets":{"value":4429256000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_noncurrent_assets":{"value":2070651000.0,"unit":"USD","label":"Other Non-current Assets","order":350}},"income_statement":{"net_income_loss":{"value":1198511000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"selling_general_and_administrative_expenses":{"value":1320433000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"nonoperating_income_loss":{"value":-1080000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"revenues":{"value":5872227000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"gross_profit":{"value":5669720000.0,"unit":"USD","label":"Gross Profit","order":800},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"diluted_earnings_per_share":{"value":10.34,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_average_shares":{"value":106338000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_tax_expense_benefit_current":{"value":560991000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"net_income_loss_available_to_common_stockholders_basic":{"value":1198511000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_loss_before_equity_method_investments":{"value":2078511000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_income_loss":{"value":2079591000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"benefits_costs_expenses":{"value":3793716000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_average_shares":{"value":115954000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"costs_and_expenses":{"value":3792636000.0,"unit":"USD","label":"Costs And Expenses","order":600},"other_operating_expenses":{"value":194554000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"research_and_development":{"value":2075142000.0,"unit":"USD","label":"Research and Development","order":1030},"cost_of_revenue_goods":{"value":202507000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_tax_expense_benefit_deferred":{"value":319009000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"income_loss_from_continuing_operations_after_tax":{"value":1198511000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_loss_from_continuing_operations_before_tax":{"value":2078511000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_attributable_to_parent":{"value":1198511000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_tax_expense_benefit":{"value":880000000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_earnings_per_share":{"value":11.27,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"cost_of_revenue":{"value":202507000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"operating_expenses":{"value":3590129000.0,"unit":"USD","label":"Operating Expenses","order":1000}},"comprehensive_income":{"comprehensive_income_loss":{"value":1211991000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":13480000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":1211991000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}}}},{"start_date":"2018-01-01","end_date":"2018-03-31","filing_date":"2018-05-03","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2018","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-18-000020","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-18-000020/files/regn-20180331.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":13427000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":206758000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":618743000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-425412000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-425412000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":13427000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":618743000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":206758000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"balance_sheet":{"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":3724335000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity":{"value":6567644000.0,"unit":"USD","label":"Equity","order":1400},"current_assets":{"value":4544732000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":9372696000.0,"unit":"USD","label":"Assets","order":100},"other_noncurrent_assets":{"value":2433237000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities_and_equity":{"value":9372696000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":1539312000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":2805052000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_assets":{"value":4827964000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":1265740000.0,"unit":"USD","label":"Current Liabilities","order":700},"inventory":{"value":820397000.0,"unit":"USD","label":"Inventory","order":230},"fixed_assets":{"value":2394727000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_parent":{"value":6567644000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600}},"income_statement":{"income_loss_before_equity_method_investments":{"value":585398000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"other_operating_expenses":{"value":45655000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"operating_income_loss":{"value":567231000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"revenues":{"value":1511500000.0,"unit":"USD","label":"Revenues","order":100},"nonoperating_income_loss":{"value":18167000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"research_and_development":{"value":498586000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_expenses":{"value":875011000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_earnings_per_share":{"value":4.16,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"diluted_average_shares":{"value":114906000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":478000000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"basic_average_shares":{"value":107648000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_available_to_common_stockholders_basic":{"value":478000000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"cost_of_revenue_goods":{"value":69243000.0,"unit":"USD","label":"Cost Of Revenue, Goods","order":400},"income_loss_from_continuing_operations_after_tax":{"value":478000000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"costs_and_expenses":{"value":944254000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":107418000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"gross_profit":{"value":1442242000.0,"unit":"USD","label":"Gross Profit","order":800},"selling_general_and_administrative_expenses":{"value":330770000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_loss_from_continuing_operations_before_tax":{"value":585398000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"interest_expense_operating":{"value":6439000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"basic_earnings_per_share":{"value":4.44,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"cost_of_revenue":{"value":69243000.0,"unit":"USD","label":"Cost Of Revenue","order":300},"net_income_loss_attributable_to_parent":{"value":478000000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":468339000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":478000000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2018-04-01","end_date":"2018-06-30","filing_date":"2018-08-02","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2018","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-18-000028","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-18-000028/files/regn-20180630.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":394565000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":-484973000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":394565000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-484973000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":-101615000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":-11207000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":-101615000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities_continuing":{"value":-11207000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":551400000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":555394000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"income_loss_before_equity_method_investments":{"value":656074000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_available_to_common_stockholders_basic":{"value":551400000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss":{"value":551400000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"other_operating_expenses":{"value":91661000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_tax_expense_benefit":{"value":104662000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_earnings_per_share":{"value":5.12,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"selling_general_and_administrative_expenses":{"value":364884000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"research_and_development":{"value":529289000.0,"unit":"USD","label":"Research and Development","order":1030},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"costs_and_expenses":{"value":985834000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_income_loss":{"value":622188000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"nonoperating_income_loss":{"value":33886000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_loss_from_continuing_operations_before_tax":{"value":656074000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_attributable_to_parent":{"value":551400000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":551400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"revenues":{"value":1608000000.0,"unit":"USD","label":"Revenues","order":100},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"diluted_average_shares":{"value":114477000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"operating_expenses":{"value":985834000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_earnings_per_share":{"value":4.82,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"interest_expense_operating":{"value":6918000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"basic_average_shares":{"value":107800000.0,"unit":"shares","label":"Basic Average Shares","order":4400}},"balance_sheet":{"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities_and_equity":{"value":9951980000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":1434364000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_noncurrent_assets":{"value":2675449000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"assets":{"value":9951980000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":2765554000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":928553000.0,"unit":"USD","label":"Inventory","order":230},"equity":{"value":7186426000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":5137063000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":1331190000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_assets":{"value":3886364000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_parent":{"value":7186426000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_assets":{"value":4814917000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":2461614000.0,"unit":"USD","label":"Fixed Assets","order":320}}}},{"start_date":"2018-07-01","end_date":"2018-09-30","filing_date":"2018-11-06","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2018","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-18-000036","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-18-000036/files/regn-20180930.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":-286708000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":3714000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":169967000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-286708000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":3714000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":452961000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":452961000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":169967000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"income_statement":{"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"research_and_development":{"value":556972000.0,"unit":"USD","label":"Research and Development","order":1030},"income_loss_before_equity_method_investments":{"value":635861000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"nonoperating_income_loss":{"value":8938000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"basic_earnings_per_share":{"value":5.5,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"diluted_average_shares":{"value":115088000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":594700000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"basic_average_shares":{"value":108033000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_after_tax":{"value":594700000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit":{"value":41206000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"selling_general_and_administrative_expenses":{"value":369232000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"other_operating_expenses":{"value":110369000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_earnings_per_share":{"value":5.17,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"operating_income_loss":{"value":626923000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_from_continuing_operations_before_tax":{"value":635861000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"interest_expense_operating":{"value":7494000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss":{"value":594700000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":1036573000.0,"unit":"USD","label":"Costs And Expenses","order":600},"revenues":{"value":1663500000.0,"unit":"USD","label":"Revenues","order":100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"operating_expenses":{"value":1036573000.0,"unit":"USD","label":"Operating Expenses","order":1000},"benefits_costs_expenses":{"value":0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"net_income_loss_available_to_common_stockholders_basic":{"value":594700000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":595748000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":594700000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"balance_sheet":{"inventory":{"value":1039679000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":7868300000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"liabilities":{"value":2937313000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":4679904000.0,"unit":"USD","label":"Other Current Assets","order":250},"liabilities_and_equity":{"value":10805613000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity":{"value":7868300000.0,"unit":"USD","label":"Equity","order":1400},"other_noncurrent_assets":{"value":2561584000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"assets":{"value":10805613000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":2524446000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_liabilities":{"value":1520083000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_liabilities":{"value":1417230000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":5086030000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":5719583000.0,"unit":"USD","label":"Current Assets","order":200}}}},{"start_date":"2018-01-01","end_date":"2018-12-31","filing_date":"2019-02-07","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2018","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-19-000009","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-19-000009/files/regn-20181231.xml","financials":{"balance_sheet":{"inventory":{"value":1151200000.0,"unit":"USD","label":"Inventory","order":230},"accounts_payable":{"value":218200000.0,"unit":"USD","label":"Accounts Payable","order":710},"wages":{"value":261800000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_assets":{"value":5286900000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_noncurrent_assets":{"value":2711100000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":6447600000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities_and_equity":{"value":11734500000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_liabilities":{"value":1442800000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":2977200000.0,"unit":"USD","label":"Liabilities","order":600},"other_current_assets":{"value":5296400000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity":{"value":8757300000.0,"unit":"USD","label":"Equity","order":1400},"assets":{"value":11734500000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":2575800000.0,"unit":"USD","label":"Fixed Assets","order":320},"other_current_liabilities":{"value":962800000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":8757300000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_liabilities":{"value":1534400000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800}},"income_statement":{"selling_general_and_administrative_expenses":{"value":1556200000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_tax_expense_benefit":{"value":109100000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"research_and_development":{"value":2186100000.0,"unit":"USD","label":"Research and Development","order":1030},"interest_expense_operating":{"value":28200000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"diluted_earnings_per_share":{"value":21.29,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss_available_to_common_stockholders_basic":{"value":2444400000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"revenues":{"value":6710800000.0,"unit":"USD","label":"Revenues","order":100},"costs_and_expenses":{"value":4176400000.0,"unit":"USD","label":"Costs And Expenses","order":600},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss":{"value":2444400000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_after_tax":{"value":2444400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_income_loss":{"value":2534400000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"basic_earnings_per_share":{"value":22.65,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_tax_expense_benefit_deferred":{"value":-140000000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"other_operating_expenses":{"value":434100000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_attributable_to_parent":{"value":2444400000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_before_tax":{"value":2553500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"diluted_average_shares":{"value":114800000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"nonoperating_income_loss":{"value":19100000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"operating_expenses":{"value":4176400000.0,"unit":"USD","label":"Operating Expenses","order":1000},"basic_average_shares":{"value":107900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_before_equity_method_investments":{"value":2553500000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_tax_expense_benefit_current":{"value":249100000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"benefits_costs_expenses":{"value":4157300000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":-6300000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":2438100000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":2438100000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":2195100000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":-77100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":655000000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":655000000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":-77100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":2195100000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-1463000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-1463000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}}}},{"start_date":"2019-01-01","end_date":"2019-03-31","filing_date":"2019-05-07","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2019","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS INC","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-19-000017","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-19-000017/files/regn-20190331.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":897000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":240800000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":897000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-776100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":240800000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-776100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":119900000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_financing_activities":{"value":119900000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"comprehensive_income":{"comprehensive_income_loss":{"value":461100000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":15100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":476200000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"other_noncurrent_assets":{"value":3313400000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":5926200000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":9444700000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_assets":{"value":6928600000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":12854800000.0,"unit":"USD","label":"Assets","order":100},"liabilities_and_equity":{"value":12854800000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_assets":{"value":5719800000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_liabilities":{"value":1511400000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity":{"value":9444700000.0,"unit":"USD","label":"Equity","order":1400},"fixed_assets":{"value":2612800000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities":{"value":3410100000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":1208800000.0,"unit":"USD","label":"Inventory","order":230}},"income_statement":{"benefits_costs_expenses":{"value":1231800000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"research_and_development":{"value":641800000.0,"unit":"USD","label":"Research and Development","order":1030},"interest_expense_operating":{"value":7700000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"costs_and_expenses":{"value":1231800000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":85000000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"selling_general_and_administrative_expenses":{"value":410800000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"basic_earnings_per_share":{"value":4.23,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_attributable_to_parent":{"value":461100000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_before_tax":{"value":546100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss":{"value":461100000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"basic_average_shares":{"value":108900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_after_tax":{"value":461100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_available_to_common_stockholders_basic":{"value":461100000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_expenses":{"value":1231800000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_before_equity_method_investments":{"value":546100000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"revenues":{"value":1711800000.0,"unit":"USD","label":"Revenues","order":100},"operating_income_loss":{"value":480000000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"nonoperating_income_loss":{"value":66100000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"other_operating_expenses":{"value":179200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_earnings_per_share":{"value":3.99,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"diluted_average_shares":{"value":115500000.0,"unit":"shares","label":"Diluted Average Shares","order":4500}}}},{"start_date":"2019-04-01","end_date":"2019-06-30","filing_date":"2019-08-06","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2019","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-19-000026","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-19-000026/files/regn-063019x10q_htm.xml","financials":{"income_statement":{"benefits_costs_expenses":{"value":1618100000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"diluted_average_shares":{"value":114600000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_available_to_common_stockholders_basic":{"value":193100000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"basic_average_shares":{"value":109200000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"basic_earnings_per_share":{"value":1.77,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_after_tax":{"value":193100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_loss_before_equity_method_investments":{"value":224700000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_loss_from_continuing_operations_before_tax":{"value":224700000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"nonoperating_income_loss":{"value":-90900000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"income_tax_expense_benefit":{"value":31600000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"operating_expenses":{"value":1618100000.0,"unit":"USD","label":"Operating Expenses","order":1000},"selling_general_and_administrative_expenses":{"value":417300000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"interest_expense_operating":{"value":8000000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"operating_income_loss":{"value":315600000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"revenues":{"value":1933700000.0,"unit":"USD","label":"Revenues","order":100},"other_operating_expenses":{"value":152500000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_earnings_per_share":{"value":1.68,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"research_and_development":{"value":1048300000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss":{"value":193100000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":1618100000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_parent":{"value":193100000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500}},"balance_sheet":{"fixed_assets":{"value":2676600000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities_and_equity":{"value":13173600000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":9755900000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":6522600000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"assets":{"value":13173600000.0,"unit":"USD","label":"Assets","order":100},"other_current_assets":{"value":5333800000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_parent":{"value":9755900000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_liabilities":{"value":1713100000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":3417700000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":1317200000.0,"unit":"USD","label":"Inventory","order":230},"other_noncurrent_assets":{"value":3846000000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":6651000000.0,"unit":"USD","label":"Current Assets","order":200}},"comprehensive_income":{"comprehensive_income_loss":{"value":193100000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":13000000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":206100000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"cash_flow_statement":{"net_cash_flow_continuing":{"value":-663000000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":-663000000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":188300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-836000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-15300000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":188300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-15300000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-836000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}}}},{"start_date":"2019-07-01","end_date":"2019-09-30","filing_date":"2019-11-05","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2019","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-19-000034","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-19-000034/files/regn-093019x10q_htm.xml","financials":{"income_statement":{"revenues":{"value":2048400000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_attributable_to_parent":{"value":669600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"nonoperating_income_loss":{"value":30000000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_loss_from_continuing_operations_before_tax":{"value":768500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"diluted_earnings_per_share":{"value":5.86,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"selling_general_and_administrative_expenses":{"value":419900000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"operating_income_loss":{"value":738500000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"other_operating_expenses":{"value":226600000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_earnings_per_share":{"value":6.12,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"operating_expenses":{"value":1309900000.0,"unit":"USD","label":"Operating Expenses","order":1000},"basic_average_shares":{"value":109400000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_average_shares":{"value":114200000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit":{"value":98900000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss":{"value":669600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"costs_and_expenses":{"value":1309900000.0,"unit":"USD","label":"Costs And Expenses","order":600},"research_and_development":{"value":663400000.0,"unit":"USD","label":"Research and Development","order":1030},"interest_expense_operating":{"value":7800000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_before_equity_method_investments":{"value":768500000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"benefits_costs_expenses":{"value":1309900000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_after_tax":{"value":669600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_available_to_common_stockholders_basic":{"value":669600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700}},"comprehensive_income":{"comprehensive_income_loss":{"value":669600000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":700000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":670300000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"fixed_assets":{"value":2771400000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities_and_equity":{"value":13939300000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":1669500000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_noncurrent_assets":{"value":4058800000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"noncurrent_assets":{"value":6830200000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":1765400000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_parent":{"value":10504400000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_assets":{"value":5764800000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":7109100000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":10504400000.0,"unit":"USD","label":"Equity","order":1400},"liabilities":{"value":3434900000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":1344300000.0,"unit":"USD","label":"Inventory","order":230},"assets":{"value":13939300000.0,"unit":"USD","label":"Assets","order":100}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-207000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":339300000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":557300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-11000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":557300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":339300000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":-11000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-207000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}}}},{"start_date":"2019-01-01","end_date":"2019-12-31","filing_date":"2020-02-07","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2019","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001532176-20-000008","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001532176-20-000008/files/regn-123119x10k_htm.xml","financials":{"income_statement":{"income_tax_expense_benefit_current":{"value":443900000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"revenues":{"value":7863400000.0,"unit":"USD","label":"Revenues","order":100},"nonoperating_income_loss":{"value":219300000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"selling_general_and_administrative_expenses":{"value":1834800000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"research_and_development":{"value":3036600000.0,"unit":"USD","label":"Research and Development","order":1030},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_tax_expense_benefit_deferred":{"value":-130600000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"operating_expenses":{"value":5653600000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_average_shares":{"value":114600000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"basic_earnings_per_share":{"value":19.38,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"diluted_earnings_per_share":{"value":18.46,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"operating_income_loss":{"value":2209800000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"interest_expense_operating":{"value":30200000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"other_operating_expenses":{"value":782200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss":{"value":2115800000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_attributable_to_parent":{"value":2115800000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":2115800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_loss_from_continuing_operations_before_tax":{"value":2429100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_available_to_common_stockholders_basic":{"value":2115800000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"benefits_costs_expenses":{"value":5434300000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_tax_expense_benefit":{"value":313300000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_before_equity_method_investments":{"value":2429100000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"basic_average_shares":{"value":109200000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"costs_and_expenses":{"value":5653600000.0,"unit":"USD","label":"Costs And Expenses","order":600}},"balance_sheet":{"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"accounts_payable":{"value":418100000.0,"unit":"USD","label":"Accounts Payable","order":710},"wages":{"value":344400000.0,"unit":"USD","label":"Wages","order":730},"other_current_assets":{"value":6273600000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_liabilities":{"value":2096600000.0,"unit":"USD","label":"Current Liabilities","order":700},"liabilities":{"value":3715500000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_parent":{"value":11089700000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"assets":{"value":14805200000.0,"unit":"USD","label":"Assets","order":100},"current_assets":{"value":7689100000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities_and_equity":{"value":14805200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity":{"value":11089700000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":1618900000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_liabilities":{"value":1334100000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"inventory":{"value":1415500000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_assets":{"value":7116100000.0,"unit":"USD","label":"Noncurrent Assets","order":300}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-252100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":150100000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":2430000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":-2027800000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":2430000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-252100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":150100000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-2027800000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":2149200000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss_attributable_to_parent":{"value":33400000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss":{"value":2149200000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":2149200000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}}}},{"start_date":"2020-01-01","end_date":"2020-03-31","filing_date":"2020-05-05","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2020","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-20-000011","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-20-000011/files/regn-033120x10q_htm.xml","financials":{"balance_sheet":{"equity":{"value":12133000000.0,"unit":"USD","label":"Equity","order":1400},"fixed_assets":{"value":2944600000.0,"unit":"USD","label":"Fixed Assets","order":320},"equity_attributable_to_parent":{"value":12133000000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":7113400000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_noncurrent_assets":{"value":4168800000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_liabilities":{"value":2055200000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":15757500000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"liabilities":{"value":3624500000.0,"unit":"USD","label":"Liabilities","order":600},"current_assets":{"value":8644100000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities_and_equity":{"value":15757500000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"inventory":{"value":1480900000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":7163200000.0,"unit":"USD","label":"Other Current Assets","order":250}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":335600000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":698000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-443200000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":335600000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":-443200000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":590400000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":698000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_continuing":{"value":590400000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":594400000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":624600000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":-30200000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"income_statement":{"diluted_average_shares":{"value":115100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":624600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"research_and_development":{"value":583900000.0,"unit":"USD","label":"Research and Development","order":1030},"other_operating_expenses":{"value":176900000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"revenues":{"value":1828200000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_before_tax":{"value":668600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_loss_before_equity_method_investments":{"value":668600000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"interest_expense_operating":{"value":6100000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_tax_expense_benefit":{"value":44000000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"operating_income_loss":{"value":700100000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"diluted_earnings_per_share":{"value":5.43,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"operating_expenses":{"value":1128100000.0,"unit":"USD","label":"Operating Expenses","order":1000},"basic_average_shares":{"value":109800000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_after_tax":{"value":624600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_available_to_common_stockholders_basic":{"value":624600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"selling_general_and_administrative_expenses":{"value":367300000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":1128100000.0,"unit":"USD","label":"Costs And Expenses","order":600},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"benefits_costs_expenses":{"value":1128100000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_earnings_per_share":{"value":5.69,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"nonoperating_income_loss":{"value":-31500000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss_attributable_to_parent":{"value":624600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500}}}},{"start_date":"2020-04-01","end_date":"2020-06-30","filing_date":"2020-08-05","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2020","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-20-000022","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-20-000022/files/regn-20200630_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":1453400000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities":{"value":-2612800000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":943400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":-216000000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":-2612800000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":-216000000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":943400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":1453400000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500}},"comprehensive_income":{"comprehensive_income_loss":{"value":897300000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":941900000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":44600000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"income_loss_before_equity_method_investments":{"value":918900000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"operating_expenses":{"value":1295600000.0,"unit":"USD","label":"Operating Expenses","order":1000},"other_operating_expenses":{"value":225300000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"research_and_development":{"value":722000000.0,"unit":"USD","label":"Research and Development","order":1030},"diluted_average_shares":{"value":117900000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit":{"value":21600000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"revenues":{"value":1952000000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss":{"value":897300000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_attributable_to_parent":{"value":897300000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"benefits_costs_expenses":{"value":1295600000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"selling_general_and_administrative_expenses":{"value":348300000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"nonoperating_income_loss":{"value":262500000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"operating_income_loss":{"value":656400000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"costs_and_expenses":{"value":1295600000.0,"unit":"USD","label":"Costs And Expenses","order":600},"basic_average_shares":{"value":109600000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"interest_expense_operating":{"value":9700000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"diluted_earnings_per_share":{"value":7.61,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_earnings_per_share":{"value":8.19,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_before_tax":{"value":918900000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_loss_from_continuing_operations_after_tax":{"value":897300000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_available_to_common_stockholders_basic":{"value":897300000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300}},"balance_sheet":{"current_liabilities":{"value":3702400000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity_attributable_to_parent":{"value":9057400000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_noncurrent_assets":{"value":3537100000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity":{"value":9057400000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"noncurrent_assets":{"value":6568500000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":6219300000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":7860200000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":3031400000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities_and_equity":{"value":14428700000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"assets":{"value":14428700000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":5371300000.0,"unit":"USD","label":"Liabilities","order":600},"inventory":{"value":1640900000.0,"unit":"USD","label":"Inventory","order":230}}}},{"start_date":"2020-07-01","end_date":"2020-09-30","filing_date":"2020-11-05","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2020","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-20-000030","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-20-000030/files/regn-20200930_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":-254300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-775800000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":-418100000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":612000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":-418100000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":-254300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-775800000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":612000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":842100000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":-4700000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":837400000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"other_noncurrent_assets":{"value":3848100000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities_and_equity":{"value":16084000000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_assets":{"value":6986400000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_liabilities":{"value":2337800000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity":{"value":10125500000.0,"unit":"USD","label":"Equity","order":1400},"liabilities":{"value":5958500000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_liabilities":{"value":3620700000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"assets":{"value":16084000000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_parent":{"value":10125500000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_assets":{"value":7296000000.0,"unit":"USD","label":"Other Current Assets","order":250},"inventory":{"value":1801600000.0,"unit":"USD","label":"Inventory","order":230},"fixed_assets":{"value":3138300000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_assets":{"value":9097600000.0,"unit":"USD","label":"Current Assets","order":200}},"income_statement":{"net_income_loss_attributable_to_parent":{"value":842100000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_earnings_per_share":{"value":7.39,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss_available_to_common_stockholders_basic":{"value":842100000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"benefits_costs_expenses":{"value":1240900000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"nonoperating_income_loss":{"value":-54800000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"operating_expenses":{"value":1240900000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss":{"value":842100000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_before_equity_method_investments":{"value":998300000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_loss_from_continuing_operations_before_tax":{"value":998300000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"interest_expense_operating":{"value":26300000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"revenues":{"value":2294000000.0,"unit":"USD","label":"Revenues","order":100},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_from_continuing_operations_after_tax":{"value":842100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"research_and_development":{"value":684600000.0,"unit":"USD","label":"Research and Development","order":1030},"diluted_average_shares":{"value":113900000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"operating_income_loss":{"value":1053100000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"selling_general_and_administrative_expenses":{"value":326900000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"basic_average_shares":{"value":105500000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"other_operating_expenses":{"value":229400000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_tax_expense_benefit":{"value":156200000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"costs_and_expenses":{"value":1240900000.0,"unit":"USD","label":"Costs And Expenses","order":600},"basic_earnings_per_share":{"value":7.98,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200}}}},{"start_date":"2020-01-01","end_date":"2020-12-31","filing_date":"2021-02-08","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2020","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-21-000008","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-21-000008/files/regn-20201231_htm.xml","financials":{"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":3521400000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":3521400000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":8200000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss_attributable_to_parent":{"value":3521400000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"current_liabilities":{"value":2697400000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":3440600000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"assets":{"value":17163300000.0,"unit":"USD","label":"Assets","order":100},"inventory":{"value":1916600000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":7862500000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity":{"value":11025300000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":7384200000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"wages":{"value":465800000.0,"unit":"USD","label":"Wages","order":730},"liabilities":{"value":6138000000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":17163300000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_parent":{"value":11025300000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_assets":{"value":9779100000.0,"unit":"USD","label":"Current Assets","order":200},"accounts_payable":{"value":475500000.0,"unit":"USD","label":"Accounts Payable","order":710},"other_current_liabilities":{"value":1756100000.0,"unit":"USD","label":"Other Current Liabilities","order":740}},"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_tax_expense_benefit_current":{"value":221600000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"operating_expenses":{"value":4920500000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":2735000000.0,"unit":"USD","label":"Research and Development","order":1030},"diluted_earnings_per_share":{"value":30.52,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"other_operating_expenses":{"value":839500000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_available_to_common_stockholders_basic":{"value":3513200000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"diluted_average_shares":{"value":115100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"costs_and_expenses":{"value":4920500000.0,"unit":"USD","label":"Costs And Expenses","order":600},"basic_average_shares":{"value":107600000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"basic_earnings_per_share":{"value":32.65,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"interest_expense_operating":{"value":56900000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_tax_expense_benefit_deferred":{"value":75600000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"net_income_loss_attributable_to_parent":{"value":3513200000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_income_loss":{"value":3576600000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"selling_general_and_administrative_expenses":{"value":1346000000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss":{"value":3513200000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit":{"value":297200000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"income_loss_from_continuing_operations_before_tax":{"value":3810400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"benefits_costs_expenses":{"value":4686700000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"nonoperating_income_loss":{"value":233800000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"revenues":{"value":8497100000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_before_equity_method_investments":{"value":3810400000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_loss_from_continuing_operations_after_tax":{"value":3513200000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400}},"cash_flow_statement":{"net_cash_flow_from_financing_activities":{"value":-1970500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":-70600000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-70600000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":2618100000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities_continuing":{"value":-1970500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":2618100000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":577000000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":577000000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}}}},{"start_date":"2021-01-01","end_date":"2021-03-31","filing_date":"2021-05-06","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2021","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-21-000017","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-21-000017/files/regn-20210331_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_continuing":{"value":-756900000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":668500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":-756900000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":668500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities":{"value":-1059000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-1059000000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-366400000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_financing_activities":{"value":-366400000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"income_statement":{"research_and_development":{"value":742900000.0,"unit":"USD","label":"Research and Development","order":1030},"other_operating_expenses":{"value":267500000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_before_equity_method_investments":{"value":1253000000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"income_loss_from_continuing_operations_before_tax":{"value":1253000000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_loss_from_continuing_operations_after_tax":{"value":1115200000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"selling_general_and_administrative_expenses":{"value":405600000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"benefits_costs_expenses":{"value":1275700000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"costs_and_expenses":{"value":1416000000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"operating_expenses":{"value":1416000000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss_available_to_common_stockholders_basic":{"value":1115200000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"nonoperating_income_loss":{"value":140300000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"diluted_earnings_per_share":{"value":10.09,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_average_shares":{"value":105400000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"revenues":{"value":2528700000.0,"unit":"USD","label":"Revenues","order":100},"diluted_average_shares":{"value":110500000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss":{"value":1115200000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"interest_expense_operating":{"value":14600000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_attributable_to_parent":{"value":1115200000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_income_loss":{"value":1112700000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit":{"value":137800000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_earnings_per_share":{"value":10.58,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":-13100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":1102100000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":1102100000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"balance_sheet":{"current_liabilities":{"value":3217800000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":17772200000.0,"unit":"USD","label":"Assets","order":100},"other_current_assets":{"value":7890400000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity":{"value":11977000000.0,"unit":"USD","label":"Equity","order":1400},"liabilities":{"value":5795200000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":17772200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"inventory":{"value":2164700000.0,"unit":"USD","label":"Inventory","order":230},"other_noncurrent_assets":{"value":4454500000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":10055100000.0,"unit":"USD","label":"Current Assets","order":200},"fixed_assets":{"value":3262600000.0,"unit":"USD","label":"Fixed Assets","order":320},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"noncurrent_assets":{"value":7717100000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity_attributable_to_parent":{"value":11977000000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600}}}},{"start_date":"2021-04-01","end_date":"2021-06-30","filing_date":"2021-08-05","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2021","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-21-000025","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-21-000025/files/regn-20210630_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-118200000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities_continuing":{"value":125800000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":626700000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-118200000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities":{"value":125800000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":634300000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":634300000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":626700000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"comprehensive_income":{"comprehensive_income_loss":{"value":3098400000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":3098400000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":-500000,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"balance_sheet":{"equity_attributable_to_parent":{"value":15127300000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"inventory":{"value":1983900000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":6358600000.0,"unit":"USD","label":"Liabilities","order":600},"other_noncurrent_assets":{"value":4789800000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"fixed_assets":{"value":3358500000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_liabilities":{"value":3732400000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_assets":{"value":8148300000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":11353700000.0,"unit":"USD","label":"Other Current Assets","order":250},"assets":{"value":21485900000.0,"unit":"USD","label":"Assets","order":100},"liabilities_and_equity":{"value":21485900000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_assets":{"value":13337600000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":15127300000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800}},"income_statement":{"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"revenues":{"value":5138500000.0,"unit":"USD","label":"Revenues","order":100},"income_loss_from_continuing_operations_before_tax":{"value":3752800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"research_and_development":{"value":714200000.0,"unit":"USD","label":"Research and Development","order":1030},"diluted_earnings_per_share":{"value":27.97,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_loss_before_equity_method_investments":{"value":3752800000.0,"unit":"USD","label":"Income/Loss Before Equity Method Investments","order":1300},"benefits_costs_expenses":{"value":1385700000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_tax_expense_benefit":{"value":653900000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"nonoperating_income_loss":{"value":405600000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_available_to_common_stockholders_basic":{"value":3098900000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"other_operating_expenses":{"value":662400000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"costs_and_expenses":{"value":1791300000.0,"unit":"USD","label":"Costs And Expenses","order":600},"selling_general_and_administrative_expenses":{"value":414700000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss":{"value":3098900000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"basic_earnings_per_share":{"value":29.51,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"operating_income_loss":{"value":3347200000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_from_continuing_operations_after_tax":{"value":3098900000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"diluted_average_shares":{"value":110800000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"basic_average_shares":{"value":105000000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"interest_expense_operating":{"value":14400000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_attributable_to_parent":{"value":3098900000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_expenses":{"value":1791300000.0,"unit":"USD","label":"Operating Expenses","order":1000}}}},{"start_date":"2021-07-01","end_date":"2021-09-30","filing_date":"2021-11-04","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2021","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-21-000033","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-21-000033/files/regn-20210930_htm.xml","financials":{"income_statement":{"net_income_loss_attributable_to_parent":{"value":1632200000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_expenses":{"value":1605600000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_after_tax":{"value":1632200000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"basic_earnings_per_share":{"value":15.37,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"benefits_costs_expenses":{"value":1636200000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"costs_and_expenses":{"value":1605600000.0,"unit":"USD","label":"Costs And Expenses","order":600},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"interest_expense_operating":{"value":14200000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"research_and_development":{"value":665400000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_income_loss":{"value":1847200000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"other_operating_expenses":{"value":495200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"basic_average_shares":{"value":106200000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_before_tax":{"value":1816600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"selling_general_and_administrative_expenses":{"value":445000000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"revenues":{"value":3452800000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_available_to_common_stockholders_basic":{"value":1632200000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"diluted_earnings_per_share":{"value":14.33,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"diluted_average_shares":{"value":113900000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"nonoperating_income_loss":{"value":-30600000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss":{"value":1632200000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_tax_expense_benefit":{"value":184400000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200}},"balance_sheet":{"liabilities":{"value":6413500000.0,"unit":"USD","label":"Liabilities","order":600},"liabilities_and_equity":{"value":23671500000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_parent":{"value":17258000000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_liabilities":{"value":2698700000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity":{"value":17258000000.0,"unit":"USD","label":"Equity","order":1400},"other_noncurrent_assets":{"value":6500400000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":13775400000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_assets":{"value":11721600000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_assets":{"value":9896100000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":23671500000.0,"unit":"USD","label":"Assets","order":100},"fixed_assets":{"value":3395700000.0,"unit":"USD","label":"Fixed Assets","order":320},"current_liabilities":{"value":3714800000.0,"unit":"USD","label":"Current Liabilities","order":700},"inventory":{"value":2053800000.0,"unit":"USD","label":"Inventory","order":230}},"comprehensive_income":{"comprehensive_income_loss":{"value":1626000000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":1626000000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-6200000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":385400000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":1360200000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":3413600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":3413600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-2438800000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-2438800000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":1360200000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":385400000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}}}},{"start_date":"2021-01-01","end_date":"2021-12-31","filing_date":"2022-02-07","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2021","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-22-000007","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-22-000007/files/regn-20211231_htm.xml","financials":{"balance_sheet":{"inventory":{"value":1951300000.0,"unit":"USD","label":"Inventory","order":230},"accounts_payable":{"value":564000000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_liabilities":{"value":2733500000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"current_liabilities":{"value":3932500000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_current_liabilities":{"value":2927800000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"liabilities_and_equity":{"value":25434800000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"liabilities":{"value":6666000000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_assets":{"value":11419900000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"assets":{"value":25434800000.0,"unit":"USD","label":"Assets","order":100},"current_assets":{"value":14014900000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_parent":{"value":18768800000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"wages":{"value":440700000.0,"unit":"USD","label":"Wages","order":730},"equity":{"value":18768800000.0,"unit":"USD","label":"Equity","order":1400},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":12063600000.0,"unit":"USD","label":"Other Current Assets","order":250}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":-5384700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":-1005800000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities":{"value":7081300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow":{"value":690800000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-5384700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":690800000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":7081300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":-1005800000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":8019800000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":8019800000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":-55500000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"income_statement":{"net_income_loss":{"value":8075300000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":2908100000.0,"unit":"USD","label":"Research and Development","order":1030},"revenues":{"value":16071700000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_available_to_common_stockholders_basic":{"value":8075300000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"nonoperating_income_loss":{"value":379000000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"basic_earnings_per_share":{"value":76.4,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"benefits_costs_expenses":{"value":6745900000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_tax_expense_benefit_deferred":{"value":-147100000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"diluted_earnings_per_share":{"value":71.97,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_average_shares":{"value":105700000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_tax_expense_benefit":{"value":1250500000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"income_loss_from_continuing_operations_after_tax":{"value":8075300000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_expenses":{"value":7124900000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_before_tax":{"value":9325800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_tax_expense_benefit_current":{"value":1397600000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"operating_income_loss":{"value":8946800000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"costs_and_expenses":{"value":7124900000.0,"unit":"USD","label":"Costs And Expenses","order":600},"other_operating_expenses":{"value":2391900000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_average_shares":{"value":112200000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":8075300000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"selling_general_and_administrative_expenses":{"value":1824900000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"interest_expense_operating":{"value":57300000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700}}}},{"start_date":"2022-01-01","end_date":"2022-03-31","filing_date":"2022-05-04","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2022","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-22-000015","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-22-000015/files/regn-20220331_htm.xml","financials":{"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":829600000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-143900000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":829600000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"costs_and_expenses":{"value":1706600000.0,"unit":"USD","label":"Costs And Expenses","order":600},"nonoperating_income_loss":{"value":-197400000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"net_income_loss":{"value":973500000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_after_tax":{"value":973500000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_expenses":{"value":1706600000.0,"unit":"USD","label":"Operating Expenses","order":1000},"selling_general_and_administrative_expenses":{"value":450000000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"revenues":{"value":2965100000.0,"unit":"USD","label":"Revenues","order":100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_tax_expense_benefit":{"value":87600000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_average_shares":{"value":113100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"other_operating_expenses":{"value":412800000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"benefits_costs_expenses":{"value":1904000000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"research_and_development":{"value":843800000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_average_shares":{"value":106800000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"basic_earnings_per_share":{"value":9.12,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_before_tax":{"value":1061100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_income_loss":{"value":1258500000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_available_to_common_stockholders_basic":{"value":973500000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"interest_expense_operating":{"value":13600000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_attributable_to_parent":{"value":973500000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_earnings_per_share":{"value":8.61,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-1705300000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow":{"value":461100000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-1705300000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":2101700000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":461100000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":2101700000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":64700000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_financing_activities":{"value":64700000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"balance_sheet":{"assets":{"value":26348700000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_liabilities":{"value":3007600000.0,"unit":"USD","label":"Current Liabilities","order":700},"fixed_assets":{"value":3556400000.0,"unit":"USD","label":"Fixed Assets","order":320},"liabilities_and_equity":{"value":26348700000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_assets":{"value":12042700000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"inventory":{"value":1991500000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":6434000000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_parent":{"value":19914700000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":19914700000.0,"unit":"USD","label":"Equity","order":1400},"other_noncurrent_assets":{"value":8486300000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":14306000000.0,"unit":"USD","label":"Current Assets","order":200},"other_current_assets":{"value":12314500000.0,"unit":"USD","label":"Other Current Assets","order":250},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800}}}},{"start_date":"2022-04-01","end_date":"2022-06-30","filing_date":"2022-08-03","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2022","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-22-000023","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-22-000023/files/regn-20220630_htm.xml","financials":{"income_statement":{"research_and_development":{"value":794300000.0,"unit":"USD","label":"Research and Development","order":1030},"selling_general_and_administrative_expenses":{"value":476300000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":1747300000.0,"unit":"USD","label":"Costs And Expenses","order":600},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"revenues":{"value":2857200000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_attributable_to_parent":{"value":852100000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":852100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"operating_expenses":{"value":1747300000.0,"unit":"USD","label":"Operating Expenses","order":1000},"interest_expense_operating":{"value":13100000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_earnings_per_share":{"value":7.9,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"other_operating_expenses":{"value":476700000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_before_tax":{"value":963200000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"income_tax_expense_benefit":{"value":111100000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_available_to_common_stockholders_basic":{"value":852100000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"basic_average_shares":{"value":107900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_average_shares":{"value":114000000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"diluted_earnings_per_share":{"value":7.47,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":1894000000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss":{"value":852100000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"nonoperating_income_loss":{"value":-146700000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"operating_income_loss":{"value":1109900000.0,"unit":"USD","label":"Operating Income/Loss","order":1100}},"comprehensive_income":{"comprehensive_income_loss":{"value":798400000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":798400000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-53700000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}},"balance_sheet":{"equity":{"value":20687800000.0,"unit":"USD","label":"Equity","order":1400},"current_liabilities":{"value":3033900000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":27205800000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":20687800000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_assets":{"value":11675900000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities_and_equity":{"value":27205800000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"fixed_assets":{"value":3637700000.0,"unit":"USD","label":"Fixed Assets","order":320},"inventory":{"value":2218500000.0,"unit":"USD","label":"Inventory","order":230},"other_current_assets":{"value":13311400000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":8038200000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_assets":{"value":15529900000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":6518000000.0,"unit":"USD","label":"Liabilities","order":600}},"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":564400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-101100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-413900000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-101100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":49400000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":49400000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":564400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":-413900000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}}}},{"start_date":"2022-07-01","end_date":"2022-09-30","filing_date":"2022-11-03","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2022","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-22-000031","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-22-000031/files/regn-20220930_htm.xml","financials":{"income_statement":{"nonoperating_income_loss":{"value":286100000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"basic_earnings_per_share":{"value":12.31,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"interest_expense_operating":{"value":15300000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_tax_expense_benefit":{"value":194100000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_earnings_per_share":{"value":11.66,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":1426400000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss_available_to_common_stockholders_basic":{"value":1315700000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"other_operating_expenses":{"value":272100000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"costs_and_expenses":{"value":1712500000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_expenses":{"value":1712500000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss":{"value":1315700000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_before_tax":{"value":1509800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"diluted_average_shares":{"value":112800000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"research_and_development":{"value":911300000.0,"unit":"USD","label":"Research and Development","order":1030},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_average_shares":{"value":106900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"operating_income_loss":{"value":1223700000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_loss_from_continuing_operations_after_tax":{"value":1315700000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"revenues":{"value":2936200000.0,"unit":"USD","label":"Revenues","order":100},"selling_general_and_administrative_expenses":{"value":529100000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_attributable_to_parent":{"value":1315700000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500}},"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":628900000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":96200000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":-725000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":96200000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":192300000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-725000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities_continuing":{"value":628900000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":192300000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400}},"balance_sheet":{"inventory":{"value":2412200000.0,"unit":"USD","label":"Inventory","order":230},"fixed_assets":{"value":3704200000.0,"unit":"USD","label":"Fixed Assets","order":320},"assets":{"value":27677800000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":6239000000.0,"unit":"USD","label":"Liabilities","order":600},"current_assets":{"value":15428600000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_parent":{"value":21438800000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_noncurrent_assets":{"value":7740900000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"current_liabilities":{"value":2879200000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity":{"value":21438800000.0,"unit":"USD","label":"Equity","order":1400},"intangible_assets":{"value":804100000.0,"unit":"USD","label":"Intangible Assets","order":330},"other_current_assets":{"value":13016400000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"noncurrent_liabilities":{"value":3359800000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"noncurrent_assets":{"value":12249200000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities_and_equity":{"value":27677800000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":1264400000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":1264400000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":-51300000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}}}},{"start_date":"2022-01-01","end_date":"2022-12-31","filing_date":"2023-02-06","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2022","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-23-000008","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-23-000008/files/regn-20221231_htm.xml","financials":{"balance_sheet":{"other_noncurrent_assets":{"value":12414900000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"intangible_assets":{"value":915500000.0,"unit":"USD","label":"Intangible Assets","order":330},"other_current_liabilities":{"value":2054800000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"accounts_payable":{"value":589200000.0,"unit":"USD","label":"Accounts Payable","order":710},"equity_attributable_to_parent":{"value":22664000000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_assets":{"value":13482200000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity":{"value":22664000000.0,"unit":"USD","label":"Equity","order":1400},"liabilities_and_equity":{"value":29214500000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":3409200000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"assets":{"value":29214500000.0,"unit":"USD","label":"Assets","order":100},"current_liabilities":{"value":3141300000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_assets":{"value":13330400000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities":{"value":6550500000.0,"unit":"USD","label":"Liabilities","order":600},"wages":{"value":497300000.0,"unit":"USD","label":"Wages","order":730},"current_assets":{"value":15884100000.0,"unit":"USD","label":"Current Assets","order":200},"inventory":{"value":2401900000.0,"unit":"USD","label":"Inventory","order":230}},"income_statement":{"income_loss_from_continuing_operations_after_tax":{"value":4338400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"selling_general_and_administrative_expenses":{"value":2115900000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"basic_earnings_per_share":{"value":40.51,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"operating_expenses":{"value":7434000000.0,"unit":"USD","label":"Operating Expenses","order":1000},"benefits_costs_expenses":{"value":7314100000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_tax_expense_benefit":{"value":520400000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_parent":{"value":4338400000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_average_shares":{"value":113500000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit_deferred":{"value":-746400000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"basic_average_shares":{"value":107100000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_earnings_per_share":{"value":38.22,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss_available_to_common_stockholders_basic":{"value":4338400000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"income_tax_expense_benefit_current":{"value":1266800000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"research_and_development":{"value":3592500000.0,"unit":"USD","label":"Research and Development","order":1030},"other_operating_expenses":{"value":1725600000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"costs_and_expenses":{"value":7434000000.0,"unit":"USD","label":"Costs And Expenses","order":600},"nonoperating_income_loss":{"value":119900000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_loss_from_continuing_operations_before_tax":{"value":4858800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"revenues":{"value":12172900000.0,"unit":"USD","label":"Revenues","order":100},"operating_income_loss":{"value":4738900000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss":{"value":4338400000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"interest_expense_operating":{"value":59400000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700}},"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-3784600000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":221300000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":5014900000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-1009000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_investing_activities_continuing":{"value":-3784600000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities_continuing":{"value":5014900000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities_continuing":{"value":-1009000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":221300000.0,"unit":"USD","label":"Net Cash Flow","order":1100}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":4125800000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":-212600000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":4125800000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}}}},{"start_date":"2023-01-01","end_date":"2023-03-31","filing_date":"2023-05-04","acceptance_datetime":"2023-05-04T11:14:54Z","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2023","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-23-000016","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-23-000016/files/regn-20230331_htm.xml","financials":{"balance_sheet":{"equity":{"value":23495200000.0,"unit":"USD","label":"Equity","order":1400},"assets":{"value":30059900000.0,"unit":"USD","label":"Assets","order":100},"intangible_assets":{"value":928700000.0,"unit":"USD","label":"Intangible Assets","order":330},"current_liabilities":{"value":3100100000.0,"unit":"USD","label":"Current Liabilities","order":700},"inventory":{"value":2424700000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"accounts_payable":{"value":599500000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_assets":{"value":16909200000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_assets":{"value":13150700000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities_and_equity":{"value":30059900000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"liabilities":{"value":6564700000.0,"unit":"USD","label":"Liabilities","order":600},"other_noncurrent_assets":{"value":12222000000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"other_current_assets":{"value":14484500000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_current_liabilities":{"value":2500600000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"equity_attributable_to_parent":{"value":23495200000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500}},"income_statement":{"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"costs_and_expenses":{"value":2215400000.0,"unit":"USD","label":"Costs And Expenses","order":600},"interest_expense_operating":{"value":18000000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"net_income_loss_attributable_to_parent":{"value":817800000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":817800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss":{"value":817800000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"income_loss_from_continuing_operations_before_tax":{"value":858000000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_expenses":{"value":2215400000.0,"unit":"USD","label":"Operating Expenses","order":1000},"nonoperating_income_loss":{"value":-88700000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"diluted_average_shares":{"value":114000000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"research_and_development":{"value":1101200000.0,"unit":"USD","label":"Research and Development","order":1030},"selling_general_and_administrative_expenses":{"value":601100000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"benefits_costs_expenses":{"value":2304100000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_average_shares":{"value":107100000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"revenues":{"value":3162100000.0,"unit":"USD","label":"Revenues","order":100},"income_tax_expense_benefit":{"value":40200000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"operating_income_loss":{"value":946700000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"other_operating_expenses":{"value":513100000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_available_to_common_stockholders_basic":{"value":817800000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"diluted_earnings_per_share":{"value":7.17,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"basic_earnings_per_share":{"value":7.64,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-322500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":809400000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":1367600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-235700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":-322500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow":{"value":809400000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities":{"value":-235700000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":1367600000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200}},"comprehensive_income":{"other_comprehensive_income_loss":{"value":57200000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss_attributable_to_parent":{"value":875000000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":875000000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}}}},{"start_date":"2023-04-01","end_date":"2023-06-30","filing_date":"2023-08-03","acceptance_datetime":"2023-08-03T10:56:05Z","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2023","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-23-000023","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-23-000023/files/regn-20230630_htm.xml","financials":{"income_statement":{"income_tax_expense_benefit":{"value":114500000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"basic_earnings_per_share":{"value":9.05,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"nonoperating_income_loss":{"value":66400000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"diluted_average_shares":{"value":113900000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"other_operating_expenses":{"value":404300000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"interest_expense_operating":{"value":18900000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_before_tax":{"value":1082900000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"operating_income_loss":{"value":1016500000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"net_income_loss_attributable_to_parent":{"value":968400000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_earnings_per_share":{"value":8.5,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"revenues":{"value":3158100000.0,"unit":"USD","label":"Revenues","order":100},"operating_expenses":{"value":2141600000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_after_tax":{"value":968400000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"costs_and_expenses":{"value":2141600000.0,"unit":"USD","label":"Costs And Expenses","order":600},"selling_general_and_administrative_expenses":{"value":652000000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"benefits_costs_expenses":{"value":2075200000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"net_income_loss":{"value":968400000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"net_income_loss_available_to_common_stockholders_basic":{"value":968400000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":1085300000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_average_shares":{"value":107000000.0,"unit":"shares","label":"Basic Average Shares","order":4400}},"cash_flow_statement":{"net_cash_flow_from_operating_activities":{"value":1022400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities_continuing":{"value":-614200000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow":{"value":-1978700000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_financing_activities":{"value":-614200000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":1022400000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":-2386900000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_investing_activities_continuing":{"value":-2386900000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_continuing":{"value":-1978700000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":952300000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":-16100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss":{"value":952300000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"balance_sheet":{"inventory":{"value":2507700000.0,"unit":"USD","label":"Inventory","order":230},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_parent":{"value":24017900000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_liabilities":{"value":2557100000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"assets":{"value":30657500000.0,"unit":"USD","label":"Assets","order":100},"liabilities":{"value":6639600000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_assets":{"value":13734500000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"accounts_payable":{"value":547300000.0,"unit":"USD","label":"Accounts Payable","order":710},"current_liabilities":{"value":3104400000.0,"unit":"USD","label":"Current Liabilities","order":700},"intangible_assets":{"value":953000000.0,"unit":"USD","label":"Intangible Assets","order":330},"other_current_assets":{"value":14415300000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":16923000000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":24017900000.0,"unit":"USD","label":"Equity","order":1400},"other_noncurrent_assets":{"value":12781500000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities_and_equity":{"value":30657500000.0,"unit":"USD","label":"Liabilities And Equity","order":1900}}}},{"start_date":"2023-07-01","end_date":"2023-09-30","filing_date":"2023-11-02","acceptance_datetime":"2023-11-02T11:22:07Z","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2023","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-23-000031","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-23-000031/files/regn-20230930_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow_from_investing_activities":{"value":-496300000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities":{"value":1114300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-496300000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities_continuing":{"value":-407300000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_continuing":{"value":210700000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow":{"value":210700000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":1114300000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_financing_activities":{"value":-407300000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"balance_sheet":{"assets":{"value":32163300000.0,"unit":"USD","label":"Assets","order":100},"liabilities_and_equity":{"value":32163300000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"liabilities":{"value":7258900000.0,"unit":"USD","label":"Liabilities","order":600},"intangible_assets":{"value":1017200000.0,"unit":"USD","label":"Intangible Assets","order":330},"other_noncurrent_assets":{"value":12511300000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity":{"value":24904400000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_liabilities":{"value":3660300000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":16072800000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_liabilities":{"value":3598600000.0,"unit":"USD","label":"Current Liabilities","order":700},"accounts_payable":{"value":536600000.0,"unit":"USD","label":"Accounts Payable","order":710},"other_current_liabilities":{"value":3062000000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"noncurrent_assets":{"value":13528500000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"current_assets":{"value":18634800000.0,"unit":"USD","label":"Current Assets","order":200},"equity_attributable_to_parent":{"value":24904400000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"inventory":{"value":2562000000.0,"unit":"USD","label":"Inventory","order":230}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":1028700000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":20900000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":1028700000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"income_statement":{"basic_earnings_per_share":{"value":9.48,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss":{"value":1007800000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"operating_expenses":{"value":2251700000.0,"unit":"USD","label":"Operating Expenses","order":1000},"selling_general_and_administrative_expenses":{"value":640500000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":2251700000.0,"unit":"USD","label":"Costs And Expenses","order":600},"operating_income_loss":{"value":1111000000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss_attributable_to_parent":{"value":1007800000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"diluted_earnings_per_share":{"value":8.89,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"income_tax_expense_benefit":{"value":103000000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"benefits_costs_expenses":{"value":2251900000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"interest_expense_operating":{"value":17800000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"other_operating_expenses":{"value":535900000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_loss_from_continuing_operations_before_tax":{"value":1110800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":1075300000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_average_shares":{"value":106300000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"revenues":{"value":3362700000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_available_to_common_stockholders_basic":{"value":1007800000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"diluted_average_shares":{"value":113400000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_loss_from_continuing_operations_after_tax":{"value":1007800000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"nonoperating_income_loss":{"value":-200000,"unit":"USD","label":"Nonoperating Income/Loss","order":900}}}},{"start_date":"2023-01-01","end_date":"2023-12-31","filing_date":"2024-02-05","acceptance_datetime":"2024-02-05T14:16:15Z","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2023","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-24-000009","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-24-000009/files/regn-20231231_htm.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss":{"value":157900000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_parent":{"value":4111500000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss":{"value":4111500000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200}},"income_statement":{"interest_expense_operating":{"value":73000000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"income_loss_from_continuing_operations_before_tax":{"value":4199300000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"net_income_loss":{"value":3953600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"benefits_costs_expenses":{"value":8917900000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"income_loss_from_continuing_operations_after_tax":{"value":3953600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"income_tax_expense_benefit_current":{"value":1083500000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"nonoperating_income_loss":{"value":152200000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"selling_general_and_administrative_expenses":{"value":2631300000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"net_income_loss_available_to_common_stockholders_basic":{"value":3953600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_expenses":{"value":9070100000.0,"unit":"USD","label":"Operating Expenses","order":1000},"diluted_average_shares":{"value":113700000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"revenues":{"value":13117200000.0,"unit":"USD","label":"Revenues","order":100},"income_tax_expense_benefit_deferred":{"value":-837800000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"basic_earnings_per_share":{"value":37.05,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"net_income_loss_attributable_to_parent":{"value":3953600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_income_loss":{"value":4047100000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"costs_and_expenses":{"value":9070100000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"diluted_earnings_per_share":{"value":34.77,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"other_operating_expenses":{"value":1999800000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"basic_average_shares":{"value":106700000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_tax_expense_benefit":{"value":245700000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"research_and_development":{"value":4439000000.0,"unit":"USD","label":"Research and Development","order":1030}},"balance_sheet":{"other_noncurrent_assets":{"value":12562400000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities_and_equity":{"value":33080200000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"intangible_assets":{"value":1038600000.0,"unit":"USD","label":"Intangible Assets","order":330},"current_liabilities":{"value":3423400000.0,"unit":"USD","label":"Current Liabilities","order":700},"accounts_payable":{"value":606600000.0,"unit":"USD","label":"Accounts Payable","order":710},"liabilities":{"value":7107100000.0,"unit":"USD","label":"Liabilities","order":600},"noncurrent_liabilities":{"value":3683700000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"inventory":{"value":2580500000.0,"unit":"USD","label":"Inventory","order":230},"other_current_assets":{"value":16898700000.0,"unit":"USD","label":"Other Current Assets","order":250},"current_assets":{"value":19479200000.0,"unit":"USD","label":"Current Assets","order":200},"noncurrent_assets":{"value":13601000000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"wages":{"value":618200000.0,"unit":"USD","label":"Wages","order":730},"equity_attributable_to_parent":{"value":25973100000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"equity":{"value":25973100000.0,"unit":"USD","label":"Equity","order":1400},"assets":{"value":33080200000.0,"unit":"USD","label":"Assets","order":100},"other_current_liabilities":{"value":2198600000.0,"unit":"USD","label":"Other Current Liabilities","order":740}},"cash_flow_statement":{"net_cash_flow":{"value":-381600000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-3185100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_financing_activities":{"value":-1790100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":-381200000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities":{"value":4594000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_operating_activities_continuing":{"value":4594000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities":{"value":-3185100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-1790100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"exchange_gains_losses":{"value":-400000,"unit":"USD","label":"Exchange Gains/Losses","order":1000}}}},{"start_date":"2024-01-01","end_date":"2024-03-31","filing_date":"2024-05-02","acceptance_datetime":"2024-05-02T11:13:11Z","timeframe":"quarterly","fiscal_period":"Q1","fiscal_year":"2024","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-24-000017","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-24-000017/files/regn-20240331_htm.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss_attributable_to_parent":{"value":3700000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss_attributable_to_parent":{"value":725700000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":3700000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":722000000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"balance_sheet":{"intangible_assets":{"value":1058700000.0,"unit":"USD","label":"Intangible Assets","order":330},"other_current_liabilities":{"value":2909600000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_assets":{"value":18871500000.0,"unit":"USD","label":"Current Assets","order":200},"liabilities_and_equity":{"value":34369600000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"inventory":{"value":2714900000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":7378500000.0,"unit":"USD","label":"Liabilities","order":600},"current_liabilities":{"value":3580900000.0,"unit":"USD","label":"Current Liabilities","order":700},"other_noncurrent_assets":{"value":14439400000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"equity_attributable_to_parent":{"value":26991100000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_assets":{"value":16156600000.0,"unit":"USD","label":"Other Current Assets","order":250},"equity":{"value":26991100000.0,"unit":"USD","label":"Equity","order":1400},"noncurrent_assets":{"value":15498100000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"assets":{"value":34369600000.0,"unit":"USD","label":"Assets","order":100},"accounts_payable":{"value":671300000.0,"unit":"USD","label":"Accounts Payable","order":710}},"cash_flow_statement":{"net_cash_flow_from_operating_activities_continuing":{"value":1512500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_investing_activities_continuing":{"value":-1687100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow":{"value":-128000000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_continuing":{"value":-127500000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities_continuing":{"value":47100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-1687100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":-500000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_operating_activities":{"value":1512500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":47100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"income_statement":{"diluted_earnings_per_share":{"value":6.27,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"operating_expenses":{"value":2393600000.0,"unit":"USD","label":"Operating Expenses","order":1000},"interest_expense_operating":{"value":16100000.0,"unit":"USD","label":"Interest Expense, Operating","order":2700},"revenues":{"value":3145000000.0,"unit":"USD","label":"Revenues","order":100},"net_income_loss_attributable_to_parent":{"value":722000000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"research_and_development":{"value":1248400000.0,"unit":"USD","label":"Research and Development","order":1030},"net_income_loss_available_to_common_stockholders_basic":{"value":722000000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"operating_income_loss":{"value":751400000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"basic_earnings_per_share":{"value":6.7,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"other_operating_expenses":{"value":456200000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"selling_general_and_administrative_expenses":{"value":689000000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":2393600000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit":{"value":-21300000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss":{"value":722000000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"diluted_average_shares":{"value":115100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"nonoperating_income_loss":{"value":-50700000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"basic_average_shares":{"value":107800000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_after_tax":{"value":722000000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"benefits_costs_expenses":{"value":2444300000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_before_tax":{"value":700700000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500}}}},{"start_date":"2024-04-01","end_date":"2024-06-30","filing_date":"2024-08-01","acceptance_datetime":"2024-08-01T11:15:21Z","timeframe":"quarterly","fiscal_period":"Q2","fiscal_year":"2024","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-24-000028","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-24-000028/files/regn-20240630_htm.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss_attributable_to_parent":{"value":7300000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss_attributable_to_parent":{"value":1439600000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss":{"value":7300000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":1432300000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100}},"cash_flow_statement":{"net_cash_flow_from_investing_activities_continuing":{"value":-557200000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-557200000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_operating_activities_continuing":{"value":354000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":-681600000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities":{"value":354000000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_financing_activities":{"value":-478100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_financing_activities_continuing":{"value":-478100000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"exchange_gains_losses":{"value":-300000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_continuing":{"value":-681300000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"balance_sheet":{"liabilities":{"value":7881000000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"other_current_assets":{"value":16208000000.0,"unit":"USD","label":"Other Current Assets","order":250},"liabilities_and_equity":{"value":36086800000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"other_current_liabilities":{"value":2946900000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"accounts_payable":{"value":561700000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_assets":{"value":17005200000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity":{"value":28205800000.0,"unit":"USD","label":"Equity","order":1400},"current_liabilities":{"value":3508600000.0,"unit":"USD","label":"Current Liabilities","order":700},"noncurrent_liabilities":{"value":0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_noncurrent_assets":{"value":15903000000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"inventory":{"value":2873600000.0,"unit":"USD","label":"Inventory","order":230},"assets":{"value":36086800000.0,"unit":"USD","label":"Assets","order":100},"equity_attributable_to_parent":{"value":28205800000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"intangible_assets":{"value":1102200000.0,"unit":"USD","label":"Intangible Assets","order":330},"current_assets":{"value":19081600000.0,"unit":"USD","label":"Current Assets","order":200}},"income_statement":{"other_operating_expenses":{"value":518700000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"income_tax_expense_benefit":{"value":195800000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"revenues":{"value":3547100000.0,"unit":"USD","label":"Revenues","order":100},"benefits_costs_expenses":{"value":1919000000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"basic_earnings_per_share":{"value":13.25,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"diluted_average_shares":{"value":115400000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"net_income_loss_attributable_to_parent":{"value":1432300000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"income_loss_from_continuing_operations_after_tax":{"value":1432300000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss":{"value":1432300000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"research_and_development":{"value":1200000000.0,"unit":"USD","label":"Research and Development","order":1030},"nonoperating_income_loss":{"value":558500000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"basic_average_shares":{"value":108100000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"diluted_earnings_per_share":{"value":12.41,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"operating_income_loss":{"value":1069600000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"operating_expenses":{"value":2477500000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss_available_to_common_stockholders_basic":{"value":1432300000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"selling_general_and_administrative_expenses":{"value":758800000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"costs_and_expenses":{"value":2477500000.0,"unit":"USD","label":"Costs And Expenses","order":600},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"income_loss_from_continuing_operations_before_tax":{"value":1628100000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500}}}},{"start_date":"2024-07-01","end_date":"2024-09-30","filing_date":"2024-10-31","acceptance_datetime":"2024-10-31T11:16:48Z","timeframe":"quarterly","fiscal_period":"Q3","fiscal_year":"2024","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-24-000040","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-24-000040/files/regn-20240930_htm.xml","financials":{"cash_flow_statement":{"net_cash_flow":{"value":83600000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_operating_activities_continuing":{"value":1291200000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"exchange_gains_losses":{"value":800000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities_continuing":{"value":-634000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_operating_activities":{"value":1291200000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_from_investing_activities_continuing":{"value":-574400000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-574400000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_continuing":{"value":82800000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_financing_activities":{"value":-634000000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700}},"income_statement":{"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"other_operating_expenses":{"value":555300000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"revenues":{"value":3720700000.0,"unit":"USD","label":"Revenues","order":100},"benefits_costs_expenses":{"value":2227700000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200},"operating_income_loss":{"value":1179500000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"net_income_loss":{"value":1340600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"selling_general_and_administrative_expenses":{"value":714400000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"income_loss_from_continuing_operations_before_tax":{"value":1493000000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"costs_and_expenses":{"value":2541200000.0,"unit":"USD","label":"Costs And Expenses","order":600},"diluted_earnings_per_share":{"value":11.54,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss_attributable_to_parent":{"value":1340600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"operating_expenses":{"value":2541200000.0,"unit":"USD","label":"Operating Expenses","order":1000},"net_income_loss_available_to_common_stockholders_basic":{"value":1340600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"research_and_development":{"value":1271500000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_average_shares":{"value":108100000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"nonoperating_income_loss":{"value":313500000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_tax_expense_benefit":{"value":152400000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"diluted_average_shares":{"value":116200000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"basic_earnings_per_share":{"value":12.4,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_after_tax":{"value":1340600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400}},"balance_sheet":{"liabilities_and_equity":{"value":37441900000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"noncurrent_liabilities":{"value":4455000000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"equity":{"value":29325900000.0,"unit":"USD","label":"Equity","order":1400},"other_current_liabilities":{"value":3163700000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"intangible_assets":{"value":1120100000.0,"unit":"USD","label":"Intangible Assets","order":330},"other_current_assets":{"value":16315600000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":16988200000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"liabilities":{"value":8116000000.0,"unit":"USD","label":"Liabilities","order":600},"current_assets":{"value":19333600000.0,"unit":"USD","label":"Current Assets","order":200},"assets":{"value":37441900000.0,"unit":"USD","label":"Assets","order":100},"noncurrent_assets":{"value":18108300000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"current_liabilities":{"value":3661000000.0,"unit":"USD","label":"Current Liabilities","order":700},"accounts_payable":{"value":497300000.0,"unit":"USD","label":"Accounts Payable","order":710},"inventory":{"value":3018000000.0,"unit":"USD","label":"Inventory","order":230},"equity_attributable_to_parent":{"value":29325900000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":1470700000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"comprehensive_income_loss":{"value":1470700000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"other_comprehensive_income_loss":{"value":1470700000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"other_comprehensive_income_loss_attributable_to_parent":{"value":130100000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600}}}},{"start_date":"2024-01-01","end_date":"2024-12-31","filing_date":"2025-02-05","acceptance_datetime":"2025-02-05T14:18:14Z","timeframe":"annual","fiscal_period":"FY","fiscal_year":"2024","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-25-000011","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-25-000011/files/regn-20241231_htm.xml","financials":{"balance_sheet":{"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"liabilities":{"value":8405800000.0,"unit":"USD","label":"Liabilities","order":600},"accounts_payable":{"value":789500000.0,"unit":"USD","label":"Accounts Payable","order":710},"noncurrent_liabilities":{"value":4461500000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"other_current_liabilities":{"value":2513900000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_assets":{"value":18660900000.0,"unit":"USD","label":"Current Assets","order":200},"equity":{"value":29353600000.0,"unit":"USD","label":"Equity","order":1400},"liabilities_and_equity":{"value":37759400000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"inventory":{"value":3087300000.0,"unit":"USD","label":"Inventory","order":230},"other_noncurrent_assets":{"value":17949900000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"wages":{"value":640900000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_assets":{"value":19098500000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"other_current_assets":{"value":15573600000.0,"unit":"USD","label":"Other Current Assets","order":250},"intangible_assets":{"value":1148600000.0,"unit":"USD","label":"Intangible Assets","order":330},"equity_attributable_to_parent":{"value":29353600000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"current_liabilities":{"value":3944300000.0,"unit":"USD","label":"Current Liabilities","order":700},"assets":{"value":37759400000.0,"unit":"USD","label":"Assets","order":100}},"cash_flow_statement":{"net_cash_flow_from_financing_activities_continuing":{"value":-2200500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"net_cash_flow_from_investing_activities":{"value":-2468100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"exchange_gains_losses":{"value":-700000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":-2200500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_from_operating_activities_continuing":{"value":4420500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow":{"value":-248800000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-2468100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_operating_activities":{"value":4420500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100},"net_cash_flow_continuing":{"value":-248100000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200}},"income_statement":{"income_loss_from_continuing_operations_before_tax":{"value":4779900000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"revenues":{"value":14202000000.0,"unit":"USD","label":"Revenues","order":100},"operating_expenses":{"value":10211300000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_tax_expense_benefit_deferred":{"value":-757300000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"research_and_development":{"value":5132000000.0,"unit":"USD","label":"Research and Development","order":1030},"operating_income_loss":{"value":3990700000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"nonoperating_income_loss":{"value":789200000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"income_tax_expense_benefit_current":{"value":1124600000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"basic_earnings_per_share":{"value":40.9,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"diluted_earnings_per_share":{"value":38.34,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"net_income_loss":{"value":4412600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"other_operating_expenses":{"value":2124900000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"basic_average_shares":{"value":107900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"income_loss_from_continuing_operations_after_tax":{"value":4412600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss_available_to_common_stockholders_basic":{"value":4412600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"diluted_average_shares":{"value":115100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"income_tax_expense_benefit":{"value":367300000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"costs_and_expenses":{"value":10211300000.0,"unit":"USD","label":"Costs And Expenses","order":600},"net_income_loss_attributable_to_parent":{"value":4412600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"selling_general_and_administrative_expenses":{"value":2954400000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"benefits_costs_expenses":{"value":9422100000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200}},"comprehensive_income":{"comprehensive_income_loss_attributable_to_parent":{"value":4485600000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300},"other_comprehensive_income_loss_attributable_to_parent":{"value":73000000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss":{"value":4485600000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss":{"value":4485600000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400}}}},{"start_date":"2024-01-01","end_date":"2024-12-31","filing_date":"2025-02-05","acceptance_datetime":"2025-02-05T14:18:14Z","timeframe":"ttm","fiscal_period":"TTM","fiscal_year":"2024","cik":"0000872589","sic":"2834","tickers":["REGN"],"company_name":"REGENERON PHARMACEUTICALS, INC.","source_filing_url":"https://api.polygon.io/v1/reference/sec/filings/0001804220-25-000011","source_filing_file_url":"http://api.polygon.io/v1/reference/sec/filings/0001804220-25-000011/files/regn-20241231_htm.xml","financials":{"comprehensive_income":{"other_comprehensive_income_loss":{"value":4485600000.0,"unit":"USD","label":"Other Comprehensive Income/Loss","order":400},"comprehensive_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Noncontrolling Interest","order":200},"other_comprehensive_income_loss_attributable_to_parent":{"value":73000000.0,"unit":"USD","label":"Other Comprehensive Income/Loss Attributable To Parent","order":600},"comprehensive_income_loss":{"value":4485600000.0,"unit":"USD","label":"Comprehensive Income/Loss","order":100},"comprehensive_income_loss_attributable_to_parent":{"value":4485600000.0,"unit":"USD","label":"Comprehensive Income/Loss Attributable To Parent","order":300}},"income_statement":{"income_tax_expense_benefit":{"value":367300000.0,"unit":"USD","label":"Income Tax Expense/Benefit","order":2200},"net_income_loss_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Net Income/Loss Attributable To Noncontrolling Interest","order":3300},"revenues":{"value":14202000000.0,"unit":"USD","label":"Revenues","order":100},"other_operating_expenses":{"value":2124900000.0,"unit":"USD","label":"Other Operating Expenses","order":1040},"diluted_average_shares":{"value":115100000.0,"unit":"shares","label":"Diluted Average Shares","order":4500},"operating_expenses":{"value":10211300000.0,"unit":"USD","label":"Operating Expenses","order":1000},"income_loss_from_continuing_operations_before_tax":{"value":4779900000.0,"unit":"USD","label":"Income/Loss From Continuing Operations Before Tax","order":1500},"selling_general_and_administrative_expenses":{"value":2954400000.0,"unit":"USD","label":"Selling, General, and Administrative Expenses","order":1010},"participating_securities_distributed_and_undistributed_earnings_loss_basic":{"value":0,"unit":"USD","label":"Participating Securities, Distributed And Undistributed Earnings/Loss, Basic","order":3800},"net_income_loss_available_to_common_stockholders_basic":{"value":4412600000.0,"unit":"USD","label":"Net Income/Loss Available To Common Stockholders, Basic","order":3700},"research_and_development":{"value":5132000000.0,"unit":"USD","label":"Research and Development","order":1030},"basic_average_shares":{"value":107900000.0,"unit":"shares","label":"Basic Average Shares","order":4400},"operating_income_loss":{"value":3990700000.0,"unit":"USD","label":"Operating Income/Loss","order":1100},"income_tax_expense_benefit_current":{"value":1124600000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Current","order":2300},"costs_and_expenses":{"value":10211300000.0,"unit":"USD","label":"Costs And Expenses","order":600},"income_tax_expense_benefit_deferred":{"value":-757300000.0,"unit":"USD","label":"Income Tax Expense/Benefit, Deferred","order":2400},"net_income_loss_attributable_to_parent":{"value":4412600000.0,"unit":"USD","label":"Net Income/Loss Attributable To Parent","order":3500},"preferred_stock_dividends_and_other_adjustments":{"value":0,"unit":"USD","label":"Preferred Stock Dividends And Other Adjustments","order":3900},"basic_earnings_per_share":{"value":40.9,"unit":"USD / shares","label":"Basic Earnings Per Share","order":4200},"income_loss_from_continuing_operations_after_tax":{"value":4412600000.0,"unit":"USD","label":"Income/Loss From Continuing Operations After Tax","order":1400},"net_income_loss":{"value":4412600000.0,"unit":"USD","label":"Net Income/Loss","order":3200},"nonoperating_income_loss":{"value":789200000.0,"unit":"USD","label":"Nonoperating Income/Loss","order":900},"diluted_earnings_per_share":{"value":38.34,"unit":"USD / shares","label":"Diluted Earnings Per Share","order":4300},"benefits_costs_expenses":{"value":9422100000.0,"unit":"USD","label":"Benefits Costs and Expenses","order":200}},"balance_sheet":{"intangible_assets":{"value":1148600000.0,"unit":"USD","label":"Intangible Assets","order":330},"noncurrent_assets":{"value":19098500000.0,"unit":"USD","label":"Noncurrent Assets","order":300},"liabilities_and_equity":{"value":37759400000.0,"unit":"USD","label":"Liabilities And Equity","order":1900},"current_liabilities":{"value":3944300000.0,"unit":"USD","label":"Current Liabilities","order":700},"equity_attributable_to_parent":{"value":29353600000.0,"unit":"USD","label":"Equity Attributable To Parent","order":1600},"other_current_liabilities":{"value":2513900000.0,"unit":"USD","label":"Other Current Liabilities","order":740},"current_assets":{"value":18660900000.0,"unit":"USD","label":"Current Assets","order":200},"inventory":{"value":3087300000.0,"unit":"USD","label":"Inventory","order":230},"liabilities":{"value":8405800000.0,"unit":"USD","label":"Liabilities","order":600},"equity_attributable_to_noncontrolling_interest":{"value":0,"unit":"USD","label":"Equity Attributable To Noncontrolling Interest","order":1500},"equity":{"value":29353600000.0,"unit":"USD","label":"Equity","order":1400},"other_current_assets":{"value":15573600000.0,"unit":"USD","label":"Other Current Assets","order":250},"other_noncurrent_assets":{"value":17949900000.0,"unit":"USD","label":"Other Non-current Assets","order":350},"assets":{"value":37759400000.0,"unit":"USD","label":"Assets","order":100},"wages":{"value":640900000.0,"unit":"USD","label":"Wages","order":730},"noncurrent_liabilities":{"value":4461500000.0,"unit":"USD","label":"Noncurrent Liabilities","order":800},"accounts_payable":{"value":789500000.0,"unit":"USD","label":"Accounts Payable","order":710}},"cash_flow_statement":{"net_cash_flow":{"value":-248800000.0,"unit":"USD","label":"Net Cash Flow","order":1100},"net_cash_flow_from_investing_activities_continuing":{"value":-2468100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities, Continuing","order":500},"net_cash_flow_from_investing_activities":{"value":-2468100000.0,"unit":"USD","label":"Net Cash Flow From Investing Activities","order":400},"net_cash_flow_from_financing_activities_continuing":{"value":-2200500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities, Continuing","order":800},"exchange_gains_losses":{"value":-700000,"unit":"USD","label":"Exchange Gains/Losses","order":1000},"net_cash_flow_from_financing_activities":{"value":-2200500000.0,"unit":"USD","label":"Net Cash Flow From Financing Activities","order":700},"net_cash_flow_continuing":{"value":-248100000.0,"unit":"USD","label":"Net Cash Flow, Continuing","order":1200},"net_cash_flow_from_operating_activities_continuing":{"value":4420500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities, Continuing","order":200},"net_cash_flow_from_operating_activities":{"value":4420500000.0,"unit":"USD","label":"Net Cash Flow From Operating Activities","order":100}}}}],"status":"OK","request_id":"7e8aa933da75bf1d7b640e5a61eff18b"}
